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Effectiveness of interventions for diagnosis and treatment of tuberculosis in hard-
to-reach populations in countries of low and medium tuberculosis incidence: a 
systematic review 
 
Supplementary Material I: PICOS (Population – Intervention – Comparator – Outcome – Study 
design)  
 
1. Review questions 
The primary review question was:  
What interventions are effective and cost-effective at identifying and managing TB and/or raising 
awareness about TB among hard-to-reach populations?  
 
Secondary review questions were: 
(i) What factors affect the effectiveness of those interventions?  
(ii) How transferable are the findings on effectiveness across hard-to-reach populations or 
settings? 
(iii) What, if any, are the adverse or unintended effects (for example, increased stigma) of the 
interventions to identify and manage individuals with TB in hard-to-reach populations? 
 
2. PICOS 
Population 
Hard-to-reach populations, like: - homeless people including rough sleepers and shelter users - people who abuse drugs or alcohol  - sex workers - prisoners or people with a history of imprisonment - migrants, including vulnerable migrant populations such as asylum seekers, refugees 
and the Roma population - children within vulnerable and hard-to-reach populations - people living with HIV 
 
Studies focusing on hard-to-reach populations from Organisation for Economic Co-operation and 
Development (OECD) countries, European Union, European Economic Area (EU/EEA) countries and 
the EU candidate countries were included.  
  
EU/EEA and candidate countries    OECD countries 
1. Albania      1. Australia 
2. Austria      2. Austria 
3. Belgium      3. Belgium 
4. Bulgaria      4. Canada 
5. Croatia      5. Chile 
6. Cyprus      6. Czech Republic 
7. Czech Republic     7. Denmark 
8. Denmark      8. Estonia 
9. Estonia      9. Finland 
10. Finland      10. France 
11. France      11. Germany 
12. Germany      12. Greece 
13. Greece      13. Hungary 
14. Hungary      14. Iceland 
15. Iceland      15. Ireland 
16. Ireland      16. Israel 
17. Italy       17. Italy 
18. Latvia      18. Japan 
19. Liechtenstein      19. Korea 
20. Lithuania      20 Luxembourg 
21. Luxembourg      21. Mexico 
22. Malta      22. Netherlands 
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23. Montenegro      23. New Zealand 
24. Netherlands      24. Norway 
25. Norway      25. Poland 
26. Poland      26. Portugal 
27. Portugal      27. Slovak Republic 
28. Romania      28. Slovenia 
29. Serbia      29. Spain 
30. Slovakia      30. Sweden 
31. Slovenia      31. Switzerland 
32. Spain      32. Turkey 
33. Sweden      33. United Kingdom 
34. The former Yugoslav Republic of Macedonia  34. United States 
35. Turkey 
36. United Kingdom  
 
Studies that do not specifically look at any of these target populations or were conducted in a different 
geographical area were excluded. 
 
Intervention 
This review aimed to collect evidence on all areas of interventions related to the identification and 
management of tuberculosis (TB) in hard-to-reach populations, predefined interventions included in the 
protocol were: 
- Active screening and case finding by:  
• tracing household contacts  
• using (mobile) chest X-rays  
• using tuberculin skin tests, interferon gamma release assays, only if used as an initial 
step in the diagnostic pathway to identify active TB cases 
• symptom-based questionnaires  
- Improve coverage and uptake of screening, active case finding, case holding and treatment by: 
• using small monetary incentives or food vouchers 
• identifying more members of hard-to-reach populations 
• (family based) DOT(S) programme  
• legal detention to manage active TB  
• continuity of care in the public sector for prisoners released from prison 
- Educational interventions: 
• information and education among vulnerable groups as well as health care providers 
and staff of social welfare and Non Governmental Organisations (NGO) that interact 
with the vulnerable populations  
• group discussion (over more traditional education methods) 
- Social care support e.g.:  
• provision of housing 
• nutritional programmes 
• addressing challenges related to immigration from high-TB burden countries 
• addressing inequalities and socioeconomic deprivation - Test and treat  
- Treatment of comorbidities, including HIV and substance use disorders 
- Enhanced case management  
- Stigma-related interventions   
- Programmes aimed at detection of patients from vulnerable or hard-to-reach populations who were 
lost to follow-up  
- The existence of programs aimed at collaborations with, or interventions aimed at, alternative, 
traditional, and / or spiritual medicine in TB treatment  
 
The following interventions were identified in the review process: 
- Pre- and post-migration screening 
- Sputum smear and sputum culture as part of pre-migration screening 
 
Comparator 
Not relevant. 
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The comparator was re-defined during the review process into:  
Every intervention group was compared to a relevant comparison group. These included for example, 
no intervention or usual care, another intervention, or historical comparison.  
 
Outcome 
Primary outcome measures were quantitative outcomes focusing on the effectiveness and cost-
effectiveness of interventions to improve TB identification and management as well as raising awareness 
about TB targeting hard-to-reach populations, including a qualitative description of these interventions.  
The secondary outcome measures were the factors that impact the effectiveness of the intervention, the 
transferability of the findings regarding effectiveness to other hard-to-reach populations or other 
settings, the adverse and unintended effects of the interventions to identify and manage those 
individuals with TB from hard-to-reach populations. 
 
Study design 
Randomised controlled trials (RCTs) focusing on interventions on the selected hard-to-reach populations 
were included. Since it is very likely that few RCTs will be identified, we also included non-randomised 
quantitative and qualitative studies, like, but not exclusively, case-control studies, cohort studies, cross-
sectional studies, observational studies etc. Systematic reviews were included for reference checking 
only.  
 
3. Further notes on PICOS 
For this systematic review of interventions with a scoping component, a very broad and sensitive 
search was conducted to cover a wide range of interventions. Predefined interventions were included in 
our registered protocol but the list of interventions was not exclusive and interventions were added to 
the list during the review process. Supplementary Material I reflects the registered protocol. Changes 
made during the implementation of the systematic review protocol are stated at the end of each section. 
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Supplementary Material II: Search strategies  
The previous NICE review1 on the same topic was used as a framework for the search strategy and 
extended to the non- Organisation for Economic Co-operation and Development (OECD), countries of 
the European Union and European Economic Area and to the two newly included hard-to-reach groups 
(people living with HIV co-infected with TB and children within vulnerable and hard-to-reach 
populations). The search for the NICE review1 was subtracted from our search to prevent double 
screening of records. The search was conducted by René Spijker, clinical librarian at the Academic 
Medical Center in Amsterdam, the Netherlands. All studies identified by the search were imported to an 
Endnote database. The original search was done on the 10th of December 2014 and updated on the 10th 
of April 2015. 
The following two databases were used for the search: 
- MEDLINE(R) In-Process & Other Non-Indexed Citations (OvidSP) 
- Embase Classic + Embase 1947 to 2015 April 10 
 
Database Hits 
Medline + Medline In-Process 9,078 
Embase 10,255 
Total 19,333 
Total de-duplicated 13,783 
 
References: 
1.    Rizzo M, Martin A, Jamal F, et al. Evidence review on the effectiveness and cost-effectiveness of 
service models or structures to manage tuberculosis in hard-to-reach groups. London: Matrix 
evidence/National Institute for Health and Clinical Excellence 2011. https://www.nice.org.uk/guidance 
/PH37/ documents/review-4-evidence-review-on-the-effectiveness-and-cost-effectiveness-of-service-
models-or-structures-to-manage-tuberculosis-in-hardtoreach-groups-2 (last assessed March 2016). 
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1. Search in Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid 
MEDLINE(R) 1990 January 1 to 2015 April 10 
 
Hits: 9,078 
 
1 exp Tuberculosis/ or (tuberculosis or tb).ti,ab. 
2 ((hard$ adj2 reach) or (hard$ adj2 locate) or (hard$ adj2 find) or (hard$ adj2 treat) or (difficult 
adj2 locate) or (difficult adj2 engage) or social$ exclu$ or social inequalit$ or (difficult$ adj2 
reach) or (difficult$ adj2 find) or (difficult$ adj2 treat) or (christian* or church* or chapel* or 
priest* or vicar* or catholic* or catholicism or protestant* or methodist* or baptist* or Jehovah* 
or presbyterian* or anglican* or pentecostal*) or (muslim* or islam* or mosque* or 
imam*)).ti,ab. or jews/ or (jew* or judaism* or synagogue*).ti,ab. or exp religion/ or (christian* 
or church* or chapel* or priest* or vicar* or catholic* or catholicism or protestant* or methodist* 
or baptist* or Jehovah* or presbyterian* or anglican* or pentecostal*).ti,ab. or jews/ or (jew* or 
judaism* or synagogue*).ti,ab. or (sikh* or hindu* or buddhis* or temple*).ti,ab. or ((religion* or 
religious* or faith*) and (people* or person* or group* or population or neighbour* or neighbor* 
or patient* or communit*)).ti,ab. 
3 ((geograph$ or transport$ or physical) and barrier$).ti,ab. 
4 ((low$ or poor$ or negative) and (quality adj2 life)).ti,ab. 
5 ((vulnerable or disadvantaged or at risk or high risk or low socioeconomic status or neglect$ or 
affected or marginal$ or forgotten or non-associative or unengaged or hidden or excluded or 
transient or inaccessible or underserved or stigma$ or inequitable) and (people or population$ or 
communit$ or neighbourhood$1 or neighborhood$1 or group$ or area$1 or demograph$ or 
patient$ or social$)).ti,ab. or Vulnerable populations/ 
6 poverty area/ 
7 (refuser$1 or nonuser$1 or non-user$1 or non user$1 or discriminat$ or shame or prejud$ or 
racism or racial discriminat$).ti,ab. 
8 social support/ or *social conditions/ or stigma/ or Social Isolation/ or *quality of life/ or 
Prejudice/ or Socioeconomic Factors/ 
9 prisoner$1.ti,ab. 
10 (recent$ adj2 release$ adj2 (inmate$ or prison$ or detainee$ or felon$ or offender$ or convict$ or 
custod$ or detention or incarcerat$ or correctional or jail$ or penitentiar$)).ti,ab. 
11 ((prison$ or penal or penitentiar$ or correctional facilit$ or jail$ or detention centre$ or detention 
center$) and (guard$1 or population or inmate$ or system$ or remand or detainee$ or felon$ or 
offender$1 or convict$ or abscond$)).ti,ab. 
12 (parole or probation).ti,ab. 
13 *prisoners/ 
14 ((custodial adj (care or sentence)) or (incarceration or incarcerated or imprisonment)).ti,ab. 
15 (immobile or (disabled and (house bound or home bound)) or ((house or home) adj3 bound)).ti,ab. 
or Homebound Persons/ 
16 ((hous$ and (quality or damp$ or standard$ or afford$ or condition$ or dilapidat$)) or 
((emergency or temporary or inadequate or poor$ or overcrowd$ or over-crowd$ or over-
subscribed) and (hous$ or accommodation or shelter$ or hostel$ or dwelling$))).ti,ab. or 
housing/st 
17 (rough sleep$ or runaway$1 or ((homeless$ or street or destitut$) and (population or person$1 or 
people or group$ or individual$1 or shelter$ or hostel$ or accommodation$1))).ti,ab. or exp 
homeless persons/ 
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18 ((drug$ or substance) and (illegal or misus$ or abuse or intravenous or IV or problem use$ or 
illicit use$ or addict$ or dependen$ or dependant or delinquency)).ti,ab. or *Substance-Related 
Disorders/ or Drug users/ or Substance Abuse, Intravenous/ 
19 ((alcohol$ and (misus$ or abuse or problem$ use$ or problem drink$ or illicit use$ or addict$ or 
dependen$ or dependant or delinquency)) or alcoholic$1).ti,ab. or *Alcohol-Related Disorders/ or 
Alcoholics/ 
20 (prostitution or sex work$ or transactional sex$ or prostitute$1).ti,ab. or Prostitution/ 
21 (poverty or deprivation or financial hardship$ or (illitera$ or welfare benefit$ or social 
benefit$)).ti,ab. 
22 ((low-income or low income or low pay or low paid or poor or deprived or debt$ or arrear$) and 
(people or person$1 or population$1 or communit$ or group$ or social group$ or 
neighbourhood$1 or neighborhood$1 or famil$)).ti,ab. 
23 poverty/ 
24 (low$ and social class$).ti,ab. 
25 (traveller$1 or Gypsies or Gypsy or Gipsy or Romany or Roma).ti,ab. or gypsies/ 
26 (mental$ and (health or ill or illness)).ti,ab. or *mental health/ or Mentally Ill Persons/ 
27 (health care worker$1 or (health care adj2 service provi$) or (health-care adj2 provi$) or 
(((community adj1 leader$) or (community adj1 (Manag$ or advocat$ or champion$))) and 
(engag$ or involv$))).ti,ab. 
28 (complex adj2 (patient$ or Need$)).ti,ab. 
29 (outreach adj2 worker$1).ti,ab. or Community health aides/ 
30 (support adj2 worker$1).ti,ab. 
31 (case adj2 worker$1).ti,ab. 
32 (social adj2 worker$1).ti,ab. 
33 social care professional$1.ti,ab. 
34 ((social care adj2 service provi$) or (social-care adj2 provi$)).ti,ab. 
35 (((language$ or communicat$) and (barrier$ or understand$ or strateg$ or proficien$)) or translat$ 
or interpret$ or (cultur$ and competen$)).ti,ab. or Communication Barriers/ or *Language/ 
36 (immigrant$ or migrant$ or asylum or refugee$ or undocumented or foreign born or UK born or 
non-UK born or non UK born or (born adj overseas) or (displaced and (people or 
person$1))).ti,ab. or "Emigration and Immigration"/ or refugees/ 
37 "Transients and Migrants"/ 
38 "Emigrants and Immigrants"/ 
39 or/2-38 
40 Intervention$.ti,ab. or Crisis Intervention/ 
41 ((early or primary) adj2 Intervention$).ti,ab. 
42 ((person$ or individual or local$ or community or cultural or structural or supported or indicated 
or target$ or multi?component or comprehensive or pilot or media) and Intervention$).ti,ab. 
43 ((midstream or mid-stream) and intervention$).ti,ab. 
44 (Identify$ or find or finding or locat$ or trac$ or contact$ or discover$ or detect or recruit$ or 
attract$).ti,ab. 
45 (case finding or ((active or passive) adj3 case finding)).ti,ab. 
46 ((program$ or scheme$1 or service$1 or campaign$ or mobili?ation or strateg$ or measure or 
policy or policies) and (tuberculosis or tb)).ti,ab. 
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47 ((case adj3 management) or case-managed).ti,ab. or Case Management/ or Patient Care Planning/ 
or Managed Care Programs/ or Patient care management/ 
48 (case adj3 manag$ adj3 strategy).ti,ab. or continuity of patient care/ 
49 ((treat$ or diagnosis) and management).ti,ab. 
50 ((active or passive) and (Case adj3 Management)).ti,ab. 
51 (risk assess$ or risk profile or risk Indicator or care plan$).ti,ab. 
52 (service and (model$ or deliver$)).ti,ab. or delivery of health care/ or *health services/ or Urban 
health services/ 
53 ((primary adj3 healthcare) or ((primary adj3 health$) or care)).ti,ab. or exp Primary Health Care/ 
54 (nurse or ((general or family) adj3 (practice$ or practitioner$ or physicians$ or doctor$))).ti,ab. or 
Nurses/ or (exp Tuberculosis/ or (tuberculosis/ or tb/)) or Family practice/ or Physicians, Family/ 
55 ((health or extension or multi-disciplinary or multidisciplinary) and (professional$ or personal$ or 
practitioner or worker$ or partner$ or promot$ or provider or care team or care provider or unit or 
casework$ or (case adj2 work$))).ti,ab. or *Health Personnel/ or Nurses' Aides/ 
56 (social adj2 (work$ or Support$ or Outreach)).ti,ab. or social work/ or Social Support/ 
57 ((lay or allied or link) and (professional$ or practitioner$1 or worker$1 or advocate$1 or 
personnel)).ti,ab. or Allied Health Personnel/ 
58 (volunteer$ or voluntary or charit$ or third sector).ti,ab. or Voluntary Workers/ or exp Voluntary 
health agencies/ 
59 (health adj1 (center$1 or centre$1 or facilit$ or service$ or clinic$1 or hospital$1 or 
program$1)).ti,ab. or Community Health/ or "Catchment Area (Health)"/ 
60 ((day adj2 (care or hospital$ or patient$)) or workshop$).ti,ab. or day care/ 
61 rehab$.ti,ab. or rehabilitation centers/ 
62 ((dedicated or permanent or rapid access or fixed or TB or tuberculosis) and (clinic$1 or centre$1 
or center$1 or program$)).ti,ab. 
63 (((drug adj2 dependency) or substance abuse or HIV) and (unit$ or clinic$1 or centre$1 or 
center$1 or program$) and (tuberculosis or tb)).ti,ab. or Substance Abuse Treatment Centers/ 
64 (pharmac$ or dispensary).ti,ab. or Pharmacies/ or Community Pharmacy Services/ 
65 (communit$ or (support$ adj2 communit$)).ti,ab. or *Community Health Services/ or 
*Community Networks/ or Community Health Aides/ or *Community-Institutional Relations/ or 
community hospital/ or Community Health Nursing/ 
66 (directly observed treatment or directly observed therapy or (supervised adj2 treatment) or (coerc$ 
adj2 (treat$ or therapy))).ti,ab. or Directly Observed Therapy/ 
67 (ambulatory adj2 care).ti,ab. or ambulatory care/ or Ambulatory Care Facilities/ 
68 ((mobile or travel$ or transport$ or workplace or work-place or tertiary) and (health adj3 (care or 
work$ or practitioner$ or professional$ or service$ or center$1 or centre$1 or unit$1 or 
program$))).ti,ab. or Mobile Health Units/ 
69 ((mobile or travel$ or transport$ or workplace or work-place or tertiary) and (nurs$ or 
doctor$)).ti,ab. 
70 ((out adj3 hours) or (after adj3 hours) or telephone or telemedicine).ti,ab. or after-hours care/ or 
Telemedicine/ 
71 ((walk-in or walkin or walk in) adj2 (center$1 or centre$1 or service or program$ or Clinic$1 or 
Session or Assesment$1)).ti,ab. 
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72 (drop$ adj1 in adj2 (center$1 or centre$1 or service or program$ or clinic$1 or session or meeting 
or assesment$1)).ti,ab. 
73 (((health or home$ or house$) and (call$ or visit$)) or (home-care or home-based or (support$ 
adj1 hous$))).ti,ab. or Home Health Aides/ or home care services/ or *House Calls/ 
74 ((early adj2 discharge) or (recent$ adj2 discharged) or (out adj2 patient)).ti,ab. or patient care/ or 
outpatient clinics, hospital/ or patient care team/ 
75 (counselling or counseling or counsellor or counselor or (integrated counselling adj1 testing 
centre$1) or (integrated counselling adj1 testing center$1) or ICTC).ti,ab. or Counseling/ or 
Directive Counseling/ 
76 ((help adj2 group$) or (self adj2 help) or support$ or (peer adj2 peer)).ti,ab. or Self-Help Groups/ 
77 (collaborat$ or shared or (integrated adj1 care$) or ICP or network$ or co-locat$ or (one adj1 
stop)).ti,ab. or "delivery of health care, integrated"/ 
78 ((health adj2 education) or (skill adj2 mix) or (role adj2 develop$) or leadership or 
((interdisciplinary or inter-team or Professional or team) adj2 communicate$)).ti,ab. or exp Health 
Education/ or Interdisciplinary Communication/ or Leadership/ or professional-family relations/ 
or professional-patient relations/ or nurse-patient relations/ or physician-patient relations/ or 
patient relationship*.ti,ab. 
79 ((outreach or mobile$ or satellite$ or hub or spoke or rural or urban or street or pavement$1 or 
sidewalk$1 or corner or shelter or hostel or sanatorium or sanitorium or sanitarium) and 
(tuberculosis or tb)).ti,ab. 
80 or/40-79 
81 test$.ti,ab. 
82 (examination$1 or assessment$1 or identification or assay$ or detection).ti,ab. 
83 diagnosi$.ti,ab. or *diagnostic tests, routine/ 
84 ((chest adj2 x?ray) or chest radiograph or MXU).ti,ab. or Mass Chest X-Ray/ 
85 (screen$ or (new$ adj1 screen$)).ti,ab. 
86 (monitor$ or sampling).ti,ab. 
87 ((target$ or focus$ or community or population or individual$ or person$ or opportunistic or 
coerc$ or voluntary or initiated) and (test$ or diagnosis or screen$ or assay$ or detection)).ti,ab. 
88 PIT.ti,ab. 
89 provider initiated test$.ti,ab. 
90 ((rapid or prompt or quick$ or earl$ or (point adj2 care)) and (test$ or screen$ or diagnosi$ or 
assay$ or detection)).ti,ab. 
91 ((provider or anonymous or accurate or support$ or incentiv$ or counsel$) and (test$ or diagnosis 
or screen$ or assay$)).ti,ab. or Anonymous Testing/ 
92 (test$ adj2 (center$1 or centre$1 or unit$1 or setting)).ti,ab. 
93 or/81-92 
94 (acceptability or acceptable or attend$ or access$ or availab$ or non-attend$ or increas$ or 
promot$ or opt$ or particip$ or adhere$ or involvement or uptake or take-up or utiliz$ or utilis$ or 
refus$ or referr$ or self-referr$ or self-report$ or barrier$ or decreas$ or isolation or interven$ or 
aware$ or opportunit$ or advice or information or incentiv$ or recruit$ or find or finding or 
compliance or comply or retain or retention or provision or encour$ or usage).ti,ab. 
95 (socio sanitary support or reimburs$ or (social adj2 support) or ((cash or financial or money or 
monetary or economic or voucher or credit or drug$1 or methadone or telephone) adj2 (benefit$ 
or support or incentive or assist$ or credit))).ti,ab. or Reimbursement, Incentive/ 
96 (((lifestyle or behavio?r) adj2 (therapy or modif$ or chang$ or adapt$ or adopt$)) and 
(tuberculosis or tb)).ti,ab. or social marketing/ 
97 "Marketing of Health Services"/ 
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98 Attitude to health/ 
99 Health Services Accessibility/ 
100 Access to information/ 
101 Confidentiality/ 
102 Health education/ 
103 Health promotion/ 
104 Patient acceptance of health care/ 
105 Patient compliance/ 
106 Motivation/ 
107 Stigma.ti,ab. 
108 prevalence/ 
109 *Consumer Participation/ 
110 or/94-109 
111 treat$.ti,ab. or Treatment Outcome/ 
112 (directly observed treatment or directly observed therapy or (supervised adj2 treatment) or (coerc$ 
adj2 (treat$ or therapy))).ti,ab. or Directly Observed Therapy/ 
113 (disease management or (treat$ and (management or control))).ti,ab. 
114 ((adherence or compli$ or non-compli$ or default$ or finish$ or Retention or attrition or (drop 
adj1 out) or disappear$ or abscond$) and treat$).ti,ab. or exp Patient Compliance/ 
115 ((referr$ or self-referr$ or (self adj diagnos$)) and treat$).ti,ab. 
116 ((suitab$ or eligib$) and treat$).ti,ab. 
117 ((follow adj1 up) or discharge).ti,ab. or Follow-Up Studies/ 
118 ((positive or negative) and test).ti,ab. 
119 ((interrupt$ or relapse$ or stop$ or cessation or with?ld$ or avoidance or (lost adj2 follow)) and 
treat$).ti,ab. or *Withholding Treatment/ 
120 ((medicine$1 or drug or treat$) and (regimen or adherence)).ti,ab. or exp self care/ 
121 (treat$ and (appointment$ or Schedule$)).ti,ab. or "Appointments and Schedules"/ 
122 ((care adj2 seeking) and pathway$).ti,ab. 
123 ((case adj3 management) or case-managed).ti,ab. or Case Management/ or Patient Care Planning/ 
or Managed Care Programs/ or Patient care management/ 
124 (case adj3 manag$ adj3 strategy).ti,ab. or continuity of patient care/ 
125 ((case or treat$ or diagnosis) and management).ti,ab. 
126 ((active or passive) and (case adj3 management)).ti,ab. 
127 ((risk assessment or care plan$) and (case adj3 management)).ti,ab. 
128 or/111-127 
129 1 and 39 and (80 or (93 and (110 or 128))) 
130 limit 129 to yr="1990 -Current" 
131 limit 130 to "english language" 
132 (animal$ or badger$ or Cow$ or Cattle or bovine).ti,ab. or (animals/ not humans/) 
133 131 not 132 
134 limit 133 to yr="1990 - 2010" 
135 130 not 132 
136 135 not 134 
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137 (albania or bulgaria or cyprus or croatia or latvia or lithuania or luxembourg or malta or 
montenegro or romania or serbia or yugoslav or turkey).ti,ab,hw,in. 
138 1 and 137 and (80 or (93 and (110 or 128))) 
139 limit 138 to yr="1990 -Current" 
140 139 not 132 
141 140 not 135 
142 136 or 141 
 
 
2. Search in Ovid: Embase Classic+Embase 1990 January 1 to 2015 April 10 
Hits: 10,255 
 
 
1 exp *tuberculosis/ or (tuberculosis or tb).ti,ab. 
2 ((hard$ adj2 reach) or (hard$ adj2 locate) or (hard$ adj2 find) or (hard$ adj2 treat) or (difficult 
adj2 locate) or (difficult adj2 engage) or social$ exclu$ or social inequalit$ or (difficult$ adj2 
reach) or (difficult$ adj2 find) or (difficult$ adj2 treat) or (christian* or church* or chapel* or 
priest* or vicar* or catholic* or catholicism or protestant* or methodist* or baptist* or Jehovah* 
or presbyterian* or anglican* or pentecostal*) or (muslim* or islam* or mosque* or 
imam*)).ti,ab. or exp *Jew/ or (jew* or judaism* or synagogue*).ti,ab. or exp *religion/ or 
(christian* or church* or chapel* or priest* or vicar* or catholic* or catholicism or protestant* or 
methodist* or baptist* or Jehovah* or presbyterian* or anglican* or pentecostal*).ti,ab. or (jew* 
or judaism* or synagogue*).ti,ab. or (sikh* or hindu* or buddhis* or temple*).ti,ab. or ((religion* 
or religious* or faith*) and (people* or person* or group* or population or neighbour* or 
neighbor* or patient* or communit*)).ti,ab. 
3 ((geograph$ or transport$ or physical) and barrier$).ti,ab. 
4 ((low$ or poor$ or negative) and (quality adj2 life)).ti,ab. 
5 ((vulnerable or disadvantaged or at risk or high risk or low socioeconomic status or neglect$ or 
affected or marginal$ or forgotten or non-associative or unengaged or hidden or excluded or 
transient or inaccessible or underserved or stigma$ or inequitable) and (people or population$ or 
communit$ or neighbourhood$1 or neighborhood$1 or group$ or area$1 or demograph$ or 
patient$ or social$)).ti,ab. or exp *vulnerable population/ 
6 *poverty/ 
7 (refuser$1 or nonuser$1 or non-user$1 or non user$1 or discriminat$ or shame or prejud$ or 
racism or racial discriminat$).ti,ab. 
8 *social support/ or exp *social status/ or *social stigma/ or exp *social isolation/ or exp *"quality 
of life"/ or exp *prejudice/ or exp *socioeconomics/ 
9 prisoner$1.ti,ab. 
10 (recent$ adj2 release$ adj2 (inmate$ or prison$ or detainee$ or felon$ or offender$ or convict$ or 
custod$ or detention or incarcerat$ or correctional or jail$ or penitentiar$)).ti,ab. 
11 ((prison$ or penal or penitentiar$ or correctional facilit$ or jail$ or detention centre$ or detention 
center$) and (guard$1 or population or inmate$ or system$ or remand or detainee$ or felon$ or 
offender$1 or convict$ or abscond$)).ti,ab. 
12 (parole or probation).ti,ab. 
13 exp *prisoner/ 
14 ((custodial adj (care or sentence)) or (incarceration or incarcerated or imprisonment)).ti,ab. 
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15 (immobile or (disabled and (house bound or home bound)) or ((house or home) adj3 
bound)).ti,ab. or exp *homebound patient/ 
16 ((hous$ and (quality or damp$ or standard$ or afford$ or condition$ or dilapidat$)) or 
((emergency or temporary or inadequate or poor$ or overcrowd$ or over-crowd$ or over-
subscribed) and (hous$ or accommodation or shelter$ or hostel$ or dwelling$))).ti,ab. or exp 
*housing/ 
17 (rough sleep$ or runaway$1 or ((homeless$ or street or destitut$) and (population or person$1 or 
people or group$ or individual$1 or shelter$ or hostel$ or accommodation$1))).ti,ab. or exp 
*homelessness/ 
18 ((drug$ or substance) and (illegal or misus$ or abuse or intravenous or IV or problem use$ or 
illicit use$ or addict$ or dependen$ or dependant or delinquency)).ti,ab. or exp *addiction/ 
19 ((alcohol$ and (misus$ or abuse or problem$ use$ or problem drink$ or illicit use$ or addict$ or 
dependen$ or delinquency)) or alcoholic$1).ti,ab. 
20 (prostitution or sex work$ or transactional sex$ or prostitute$1).ti,ab. or Prostitution/ 
21 (poverty or deprivation or financial hardship$).ti,ab. 
22 ((low-income or low income or low pay or low paid or poor or deprived or debt$ or arrear$) and 
(people or person$1 or population$1 or communit$ or group$ or social group$ or 
neighbourhood$1 or neighborhood$1 or famil$)).ti,ab. or exp *lowest income group/ 
23 *poverty/ 
24 (low$ and social class$).ti,ab. 
25 (traveller$1 or gypsies or gypsy or Romany or roma).ti,ab. or exp *"Romani (people)"/ 
26 (mental$ and (health or ill or illness)).ti,ab. or *mental patient/ or exp *mental health/ 
27 (health care worker$1 or (health care adj2 service provi$) or (health-care adj2 provi$) or 
(((community adj1 leader$) or (community adj1 (Manag$ or advocat$ or champion$))) and 
(engag$ or involv$))).ti,ab. 
28 (complex adj2 (patient$ or Need$)).ti,ab. 
29 (outreach adj2 worker$1).ti,ab. or exp *health auxiliary/ 
30 (support adj2 worker$1).ti,ab. 
31 (case adj2 worker$1).ti,ab. 
32 (social adj2 worker$1).ti,ab. 
33 social care professional$1.ti,ab. 
34 ((social care adj2 service provi$) or (social-care adj2 provi$)).ti,ab. 
35 (((language$ or communicat$) and (barrier$ or understand$ or strateg$ or proficien$)) or translat$ 
or interpret$ or (cultur$ and competen$)).ti,ab. or *language ability/ 
36 (immigrant$ or migrant$ or asylum or refugee$ or undocumented or foreign born or (born adj 
overseas) or (displaced and (people or person$1))).ti,ab. or exp *refugee/ 
37 exp *migrant/ 
38 *immigration/ 
39 or/2-38 
40 Intervention$.ti,ab. or exp *crisis intervention/ 
41 ((early or primary) adj2 Intervention$).ti,ab. 
42 ((person$ or individual or local$ or community or cultural or structural or supported or indicated 
or target$ or multi?component or comprehensive or pilot or media) and Intervention$).ti,ab. 
43 ((midstream or mid-stream) and intervention$).ti,ab. 
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44 (Identify$ or find or finding or locat$ or trac$ or contact$ or discover$ or detect or recruit$ or 
attract$).ti,ab. 
45 (case finding or ((active or passive) adj3 case finding)).ti,ab. 
46 ((program$ or scheme$1 or service$1 or campaign$ or mobili?ation or strateg$ or measure or 
policy or policies) and (tuberculosis or tb)).ti,ab. 
47 ((case adj3 management) or case-managed).ti,ab. or *case management/ or *patient care 
planning/ or *case management/ or exp *health care management/ 
48 (case adj3 manag$ adj3 strategy).ti,ab. or continuity of * patient care/ 
49 ((treat$ or diagnosis) and management).ti,ab. 
50 ((active or passive) and (Case adj3 Management)).ti,ab. 
51 (risk assess$ or risk profile or risk Indicator or care plan$).ti,ab. 
52 (service and (model$ or deliver$)).ti,ab. or delivery of * health care/ or *health service/ 
53 ((primary adj3 healthcare) or ((primary adj3 health$) or care)).ti,ab. or exp *primary health care/ 
54 (nurse or ((general or family) adj3 (practice$ or practitioner$ or physicians$ or doctor$))).ti,ab. or 
exp *nurse/ or (exp *tuberculosis/ or (tuberculosis or tb).ti,ab.) or exp *general practice/ 
55 ((health or extension or multi-disciplinary or multidisciplinary) and (professional$ or personal$ or 
practitioner or worker$ or partner$ or promot$ or provider or care team or care provider or unit or 
casework$ or (case adj2 work$))).ti,ab. or *health care personnel/ or exp *nursing assistant/ 
56 (social adj2 (work$ or Support$ or Outreach)).ti,ab. or *social work/ or *social support/ 
57 (volunteer$ or voluntary or charit$ or third sector).ti,ab. or *voluntary worker/ or exp *health care 
organization/ 
58 (health adj1 (center$1 or centre$1 or facilit$ or service$ or clinic$1 or hospital$1 or 
program$1)).ti,ab. or *public health/ or *residential care/ 
59 ((day adj2 (care or hospital$ or patient$)) or workshop$).ti,ab. or *day care/ 
60 rehab$.ti,ab. or *rehabilitation center/ 
61 ((dedicated or permanent or rapid access or fixed or TB or tuberculosis) and (clinic$1 or centre$1 
or center$1 or program$)).ti,ab. 
62 (((drug adj2 dependency) or substance abuse or HIV) and (unit$ or clinic$1 or centre$1 or 
center$1 or program$) and (tuberculosis or tb)).ti,ab. 
63 (pharmac$ or dispensary).ti,ab. or *pharmacy/ 
64 (communit$ or (support$ adj2 communit$)).ti,ab. or *community care/ or *health auxiliary/ or 
*public relations/ or *community hospital/ or *community health nursing/ 
65 (directly observed treatment or directly observed therapy or (supervised adj2 treatment) or 
(coerc$ adj2 (treat$ or therapy))).ti,ab. or Directly Observed Therapy/ 
66 (ambulatory adj2 care).ti,ab. or exp *ambulatory care/ 
67 ((mobile or travel$ or transport$ or workplace or work-place or tertiary) and (health adj3 (care or 
work$ or practitioner$ or professional$ or service$ or center$1 or centre$1 or unit$1 or 
program$))).ti,ab. or *preventive health service/ 
68 ((mobile or travel$ or transport$ or workplace or work-place or tertiary) and (nurs$ or 
doctor$)).ti,ab. 
69 ((out adj3 hours) or (after adj3 hours) or telephone or telemedicine).ti,ab. or after-hours care/ or 
exp *telehealth/ or *emergency care/ or *health care delivery/ 
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70 ((walk-in or walkin or walk in) adj2 (center$1 or centre$1 or service or program$ or Clinic$1 or 
Session or Assesment$1)).ti,ab. 
71 (drop$ adj1 in adj2 (center$1 or centre$1 or service or program$ or clinic$1 or session or meeting 
or assesment$1)).ti,ab. 
72 (((health or home$ or house$) and (call$ or visit$)) or (home-care or home-based or (support$ 
adj1 hous$))).ti,ab. or Home Health Aides/ or *health auxiliary/ or exp *home care/ 
73 ((early adj2 discharge) or (recent$ adj2 discharged) or (out adj2 patient)).ti,ab. or *patient care/ or 
*outpatient department/ 
74 (counselling or counseling or counsellor or counselor or (integrated counselling adj1 testing 
centre$1) or (integrated counselling adj1 testing center$1) or ICTC).ti,ab. or *counseling/ or 
*directive counseling/ 
75 ((help adj2 group$) or (self adj2 help) or support$ or (peer adj2 peer)).ti,ab. or *self help/ 
76 (collaborat$ or shared or (integrated adj1 care$) or ICP or network$ or co-locat$ or (one adj1 
stop)).ti,ab. or *integrated health care system/ 
77 ((health adj2 education) or (skill adj2 mix) or (role adj2 develop$) or leadership or 
((interdisciplinary or inter-team or Professional or team) adj2 communicate$)).ti,ab. or exp 
*health education/ or exp *interdisciplinary communication/ or *leadership/ or *doctor patient 
relation/ or *nurse patient relationship/ or patient relationship*.ti,ab. 
78 ((outreach or mobile$ or satellite$ or hub or spoke or rural or urban or street or pavement$1 or 
sidewalk$1 or corner or shelter or hostel or sanatorium or sanitorium or sanitarium) and 
(tuberculosis or tb)).ti,ab. 
79 ((outreach or mobile$ or satellite$ or hub or spoke or rural or urban or street or pavement$1 or 
sidewalk$1 or corner or shelter or hostel or sanatorium or sanitorium or sanitarium) and 
(tuberculosis or tb)).ti,ab. 
80 or/40-79 
81 test$.ti,ab. 
82 (examination$1 or assessment$1 or identification or assay$ or detection).ti,ab. 
83 diagnosi$.ti,ab. or *diagnostic test/ 
84 ((chest adj2 x?ray) or chest radiograph or MXU).ti,ab. or *thorax radiography/ 
85 (screen$ or (new$ adj1 screen$)).ti,ab. 
86 (monitor$ or sampling).ti,ab. 
87 ((target$ or focus$ or community or population or individual$ or person$ or opportunistic or 
coerc$ or voluntary or initiated) and (test$ or diagnosis or screen$ or assay$ or detection)).ti,ab. 
88 PIT.ti,ab. 
89 provider initiated test$.ti,ab. 
90 ((rapid or prompt or quick$ or earl$ or (point adj2 care)) and (test$ or screen$ or diagnosi$ or 
assay$ or detection)).ti,ab. 
91 ((provider or anonymous or accurate or support$ or incentiv$ or counsel$) and (test$ or diagnosis 
or screen$ or assay$)).ti,ab. or *anonymous testing/ 
92 (test$ adj2 (center$1 or centre$1 or unit$1 or setting)).ti,ab. 
93 or/81-92 
94 (acceptability or acceptable or attend$ or access$ or availab$ or non-attend$ or increas$ or 
promot$ or opt$ or particip$ or adhere$ or involvement or uptake or take-up or utiliz$ or utilis$ 
or refus$ or referr$ or self-referr$ or self-report$ or barrier$ or decreas$ or isolation or interven$ 
or aware$ or opportunit$ or advice or information or incentiv$ or recruit$ or find or finding or 
compliance or comply or retain or retention or provision or encour$ or usage).ti,ab. 
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95 (socio sanitary support or reimburs$ or (social adj2 support) or ((cash or financial or money or 
monetary or economic or voucher or credit or drug$1 or methadone or telephone) adj2 (benefit$ 
or support or incentive or assist$ or credit))).ti,ab. 
96 (((lifestyle or behavio?r) adj2 (therapy or modif$ or chang$ or adapt$ or adopt$)) and 
(tuberculosis or tb)).ti,ab. or *social marketing/ 
97 *marketing/ 
98 *attitude to health/ 
99 *health care delivery/ 
100 *access to information/ 
101 *confidentiality/ 
102 *Health education/ 
103 *health promotion/ 
104 *patient compliance/ 
105 *motivation/ 
106 Stigma.ti,ab. 
107 *prevalence/ 
108 *patient participation/ 
109 *patient attitude/ or *refusal to participate/ or *treatment refusal/ 
110 or/94-109 
111 treat$.ti,ab. or Treatment Outcome/ 
112 (directly observed treatment or directly observed therapy or (supervised adj2 treatment) or 
(coerc$ adj2 (treat$ or therapy))).ti,ab. or *directly observed therapy/ 
113 (disease management or (treat$ and (management or control))).ti,ab. 
114 ((adherence or compli$ or non-compli$ or default$ or finish$ or Retention or attrition or (drop 
adj1 out) or disappear$ or abscond$) and treat$).ti,ab. or exp *patient compliance/ 
115 ((referr$ or self-referr$ or (self adj diagnos$)) and treat$).ti,ab. 
116 ((suitab$ or eligib$) and treat$).ti,ab. 
117 ((follow adj1 up) or discharge).ti,ab. or *follow up/ 
118 ((positive or negative) and test).ti,ab. 
119 ((interrupt$ or relapse$ or stop$ or cessation or with?ld$ or avoidance or (lost adj2 follow)) and 
treat$).ti,ab. or *treatment withdrawal/ 
120 ((medicine$1 or drug or treat$) and (regimen or adherence)).ti,ab. or exp *self care/ 
121 (treat$ and (appointment$ or Schedule$)).ti,ab. or *patient scheduling/ 
122 ((care adj2 seeking) and pathway$).ti,ab. 
123 ((case adj3 management) or case-managed).ti,ab. or Case Management/ or *patient care planning/ 
or *health insurance/ 
124 (case adj3 manag$ adj3 strategy).ti,ab. or continuity.mp. or *patient care/ [mp=title, abstract, 
subject headings, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
125 ((case or treat$ or diagnosis) and management).ti,ab. 
126 ((risk assessment or care plan$) and (case adj3 management)).ti,ab. 
127 ((active or passive) and (case adj3 management)).ti,ab. 
128 or/111-127 
129 1 and 39 and (80 or (93 and (110 or 128))) 
130 limit 129 to yr="1990 -Current" 
131 limit 130 to "english language" 
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132 (exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or 
humans).ti.) 
133 131 not 132 
134 limit 133 to yr="1990 - 2010" 
135 (albania or bulgaria or cyprus or croatia or latvia or lithuania or luxembourg or malta or 
montenegro or romania or serbia or yugoslav or turkey).ti,ab,hw,in. 
136 1 and 135 and (80 or (93 and (110 or 128))) 
137 limit 136 to yr="1990 -Current" 
138 137 not 132 
139 138 not 130 
140 133 not 134 
141 139 or 140 
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Supplementary Material III. Evidence tables  
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
US/Mexico 
 
Authors: 
Assael R., Cervantes J., 
Barrera G. 
 
Year: 
2013 
 
Citation: 
Assael R., Cervantes J., 
Barrera G. 
Smears and cultures for 
diagnosis of pulmonary 
tuberculosis in an 
asymptomatic immigrant 
population.   
International Journal of 
General Medicine 2013:6 
777–779 
 
Aim of study: 
To demonstrate the 
proportion of smear-
positive/culture-positive 
cases compared with smear-
negative/culture-positive TB 
cases in Mexican immigrants 
bound for the USA 
 
Study design: 
Retrospective record study 
 
Quality score: 
- 
Source population(s): 
Immigrants 
 
Eligible population: 
Mexican immigrants to the 
US 
 
Selected population: 
Culture confirmed active 
TB in Mexican immigrants 
to the US 
 
Excluded population: 
NR 
 
Setting: 
TB screening for Mexican 
migrants to the US 
 
Sample characteristics: 
- 122 active TB 
- 42% female, 58% male 
- mean age 61.4 years (19-
93 y.o) 
-  Active TB disease was 
most prevalent in the 
Mexican state of Jalisco, 
followed by in Chihuahua, 
Guerrero, and Baja, 
California 
Method of allocation: 
All US bound immigrants 
with a positive CXR 
 
Intervention(s) 
description: 
Sputum culture for 
immigrant screening 
 
Comparator/ control(s) 
description: 
Sputum smear 
 
Baseline comparisons: 
TB confirmation by smear 
vs culture 
 
Study sufficiently 
powered?: 
NR 
Primary outcomes: 
Proportion smear vs 
culture  
 
Secondary outcomes: 
Characteristics (age, sex, 
city etc.) 
 
Method of analysis: 
Proportion 
 
Modelling method and 
assumptions: 
NR 
 
Time horizon: 
2009-2012 
Primary results: 
- 80% (n = 97) negative smears 
- 20% (n = 25) positive smears 
 
- 8/10 actual cases are being 
missed when sputum smear is the 
only diagnostic tool in 
asymptomatic patients with 
abnormal chest X-rays 
 
Secondary results: 
See characteristics 
 
Limitations identified by 
author: 
NR 
 
Limitations identified by 
review team: 
Very limited study, not 
compared with symptoms, 
no notice about drug 
sensitivity 
Not an RCT 
 
Evidence gaps and/or 
recommendations for 
future research: 
RCT, wider analysis, , 
adjust for confoudners etc.  
 
Source of funding: 
NR 
 
Conflict of interests: 
None 
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Applicability: 
+ 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
US 
 
Authors: 
Bell T.R. Molinari N.A.M., 
Blumensaadt S. et al.  
 
Year: 
2013 
 
Citation: 
Bell T.R. Molinari N.A.M., 
Blumensaadt S. et al. Impact 
of port of entry referrals on 
initiation of follow-ip 
evaluations for immigrants 
with suspected tuberculosis: 
Illinois. J Immigrant 
Minority Health (2013) 
15:673-679 
 
Aim of study: 
the efficacy of referral 
processes at US POE  
 
Study design: 
non-research program 
evaluation:  
Comparing different types of 
referral for follow up versus 
a control group 
 
Quality score: 
+ 
 
Source population(s): 
Immigrants 
 
Eligible population: 
Immigrants with suspected 
TB 
 
Selected population: 
Immigrants with suspected 
TB arriving through all 
POE between 1.10.08-
30.9.10 with final 
destination Illinois 
 
Excluded population: 
- Immigrants entered 
through Detroit, Honolulu 
or Minneapolis 
- reports with inconsistent 
or missing data 
 
Setting: 
US immigrants with 
suspected TB arriving at 
all  Port-of-Entry’s 
 
Sample characteristics: 
1512 immigrants with 
suspected TB arriving 
through all Port-of-Entry’s 
- 1218 (81%) included in 
evaluation 
- Male : Female = 
50.1%:49.8% 
- Mean age 42 years 
Method of allocation: 
Place of destination 
 
Intervention(s) 
description: 
These four categories 
included 3 referral types 
and 
a group that received no 
referral serving as the 
referent or control group 
 
Comparator/ control(s) 
description: 
No referral 
 
Baseline comparisons: 
Number of days until 
follow up 
 
Study sufficiently - 
powered?: 
Yes 
Primary outcomes: 
Difference between 
different referral types on 
domestic follow-up within 
30 days of arrival  
 
Secondary outcomes: 
Difference between 
referral types in number of 
days elapsed before follow-
up; from date of arrival 
into the United States until 
the date of initiating a TB 
follow-up evaluation, first 
clinic visit 
 
Method of analysis: 
- Pearson’s 
and Cochran-Mantel–
Haenszel Chi squared tests 
- Kaplan–Meier survival 
curves were generated 
to examine the time to 
evaluation initiation by the 
3 referral 
types and no referral 
- To compare: Cox 
proportional hazard 
models was used  
-  The effect of 
covariates was assessed 
using Wald Chi squared 
tests 
 
Primary results: 
- 733/1218 (60%) initiated F/U 
- 489/1218 (40%) in 30 days 
-  441/489 (90 %) received any 
type of referral 
*31 % receiving an appointment 
*29 % provided a direct phone 
number  
* 30 % provided an indirect 
phone number. 
 
Initiation of follow-up evaluation 
within 30 days was significantly 
related to receiving any referral 
(p<0.0001) and referral category 
(p>0.0001). 
 
The proportion of immigrants 
who initiated follow-up 
within the first 30 days of arrival 
was greatest for those 
receiving a direct phone number 
(67 %), followed by those 
receiving appointments (53 %) 
then those receiving an  indirect 
phone number (43 %). Only 11 % 
of immigrants 
receiving no referral initiated 
follow-up within 30 days. 
 
Secondary results: 
- median time to initiate follow-up 
was 20 days (range 1–602 days; 
Table 2 ).  
* Immigrants with any referral 
Limitations identified by 
author: 
- constraints of the 
appointment-scheduling 
process, in that CQS staff 
had a limited number of 
available appointment 
times with the City of 
Chicago TB clinics 
- outcome data were 
available for only 81 % of 
immigrants resettling in 
Illinois, possibly limiting 
the representativeness of 
our findings. 
-  it was not possible to 
distinguish between CQS 
referrals made in person 
during business hours 
versus by mail after 
business hours.  
- Those who received the 
referral in the mail may 
not have been so apt to 
initiate follow-up because 
they did not receive face-
to-face counselling - the 
hazard ratios could be 
underestimated 
-  not possible to 
control for other 
influences, such as pre-
migration 
instructions received 
overseas and the quality of 
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Applicability: 
++ 
- Majority of South-
Eastern Asia (47.5%), 
Americas (25.0%) and 
Eastern Europe (8.2%), 
Eastern Asia (8.1%) 
- The majority (97.4%) 
departed from another 
country than their birth 
country 
Modelling method and 
assumptions: 
- Multivariate analysis 
adjusting for covariates 
and potential confounders 
(jurisdiction of residence 
(City of Chicago, suburban 
Cook County or other 
Illinois county), region of 
birth, year of US arrival, 
age at US arrival, sex, 
overseas suspected TB 
status, and whether 
immigrants resided in a 
country other than their 
birth country before 
arriving in the United 
States)  
 
- Assumption that 
immigrants that enter via 
other POEs have had no 
referral 
 
Time horizon: 
1st of October 2008- 30th 
of September 2010 
type showed a significantly lower 
median time to 
initiate follow-up compared with 
those who received no referral 
(16 vs. 69 days, respectively; 
Wilcoxon test = 
 12.9, p<0.0001). 
 
-  Immigrants resettling in 
suburban Cook 
County and receiving a direct 
phone number had the shortest 
median time (14 days) and lowest 
maximum time 
(71 days) to initiation. 
 
Conclusion: 
immigrants receiving any referral 
initiated 
follow-up at 4 times the rate of 
those receiving no referral 
Those receiving a direct phone 
number had the highest rate of 
evaluation initiation and initiated 
follow-up evaluation at 7 times 
the rate of those receiving no 
referral 
No significant difference in rate 
of evaluation 
initiation was observed between 
those receiving a direct 
phone number and those 
receiving an appointment 
 
 
 
information 
provided by different CQS 
staff. 
-  referral type was 
determined by jurisdiction 
of destination, and it was 
therefore impossible to 
identify the independent 
effects of referral type and 
jurisdiction. 
 
Limitations identified by 
review team: 
- non-research program 
evaluation 
- small group of direct 
phone number  
- ?outcome of follow-up – 
did patients with symptoms 
come for follow-up sooner 
than patients without any 
symptoms 
 
Evidence gaps and/or 
recommendations for 
future research: 
- Different referral types in 
the same location of 
resettlement. As the place 
of resettlement might be a 
source of bias.  
- And randomisation per 
country of birth/departure 
(or TB incidence) as the 
information given in these 
countries might be of 
influence as well. 
- Evaluate the difference 
between face-to-face 
interview and referral via 
mail 
- What % of early follow-
up appointments had active 
TB versus late follow-ups 
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- Or adjust for level of 
education 
 
Source of funding: 
CDC 
 
Conflict of interests: 
NR 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
France 
 
Authors: 
Bernard C., Sougakoff W. 
Fournier A. et al. 
 
Year: 
2012 
 
Citation: 
Bernard C., Sougakoff W. 
Fournier A. et al. 
Impact of a 14-year 
screening programme on 
tuberculosis transmission 
among the homeless in 
Paris, Int J Tuberc Lung Dis 
16(5):649-655 
 
Aim of study: 
To measures the impact of 
an active TB case finding 
programme on the 
transmission of TB among 
the homeless in Paris 
 
Study design: 
Observational study 
 
Source population(s): 
Homeless 
 
Eligible population: 
All people that present to 
the shelter on the day of 
screening were invited to 
participate irrespective if 
the were regular or 
occasional users of the 
facility  
 
Selected population: 
28 shelter facilities with 
the highest number of beds 
or in which TB cases had 
already been identified 
were included in the study 
 
Excluded population: 
Shelters not having 
implemented the TB 
programme 
 
Setting: 
Homeless shelters Paris, 
France 
 
Sample characteristics: 
Not reported 
Method of allocation: 
- 
 
Intervention(s) 
description: 
Active TB case-finding 
programme implemented in 
28 shelters between end 
1994 and 1997 
 
1 day active CXR 
screening, several sessions 
per year in each shelter 
with mobile X-ray 
equipment – if CXR 
abnormal – referred to 
hospital for further 
investigations 
 
Comparator/ control(s) 
description: 
Change over time, during 
implementation and after 
implementation 
 
Baseline comparisons: 
- TB screening 
- TB cases detected 
Primary outcomes: 
Time trend of screening 
done, number of TB cases 
 
Secondary outcomes: 
Related cases -  used RFLP 
genotyping to detect 
related cases 
 
Method of analysis: 
- Poisson regression 
analysis 
- Time trends in these 3-
year moving average 
proportions were analysed 
using χ2 for trend analysis 
 
Modelling method and 
assumptions: 
NR 
The newly implemented TB 
programme has impact on 
the screening coverage and 
on the TB transmission 
 
Time horizon: 
1994 and 2007 
Primary results: 
- 514 1-day active screening 
sessions were organised in the 28 
shelters with around 22 000 
CXRs performed 
* number of CXR/per year 
increased over the 
implementation period (1994-
1997) and remained stable at 
around 2000 CXR’s/year from 
1998 to 2007 (the overall trend is 
an increase in no. CXR’s/year) – 
no change in no. of beds at 
shelters 
 
-  313 TB cases were diagnosed 
in the homeless population: 179 
shelter users, 134 non-shelter 
users 
* in shelter users the number of 
cases detected increased during 
the implementation of the 
programme between 1994-1997 
and decreased progressively after 
1997 (due to Rx and rules in some 
shelters – need a negative sputum 
sample or 2 weeks of Rx before 
returning to shelter) 
* non-shelter users fluctuated 
until 2000 and then decreased 
Limitations identified by 
author: 
- observational study 
- some cases not notified as 
homeless 
- not sure if they received a 
sample of each person 
(lab) 
- identical strains may be 
the same for other reasons 
than recent transmission 
- should be cautious with 
the association between the 
decline in related cases 
and the intervention 
- no data on Rx completion 
 
Limitations identified by 
review team: 
- Unclear which 
percentage of people 
present at shelters agreed 
to participate 
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Quality score: 
+ 
 
Applicability: 
++ 
  
Study sufficiently 
powered? 
Yes 
 
Secondary results: 
- 160/313 (51%) were related 
cases 
- related cases decreased steadily 
between 1997-2007 
* 1997-1999: crude average 
14.3/year & proportion of related 
cases among all TB cases 75%  
* 2005-2007: 2.7/year (p<0.01); 
30% (p<0.01) 
- related cases of all cases 
decreased significantly (p<0.01) 
but less in the homeless group not 
using shelters 
* 1997 4.3/year 
* 2007 2.7/years 
- non-related cases remained 
stable 
- no MDR-TB 
 
1994: 
- 58% of the homeless TB cases 
were related cases 
- related cases in homeless people 
using shelters: 88% 
- related cases in homeless people 
not using shelters: 41% 
 
Conclusion: 
TB screening programme has had 
a very positive impact on TB 
transmission in shelters  
 
- Slight indirect impact on non-
shelter users 
- Characteristics of the 
study population over time 
and possible confounders 
not assessed 
- Not RCT but comparison 
over time = important 
confounder 
 
Evidence gaps and/or 
recommendations for 
future research:  
RCT based research 
 
Source of funding: 
? Direction de l’Action 
sociale, de L’Enfance et de 
la Sante (DASES), a health 
institution supervised by 
the Paris city council 
 
Conflict of interests: 
NR 
 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
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Country: 
Vietnam for immigration to 
US 
 
Authors: 
Chuke S.O., Yen N.T.N., 
Laserson K.F. et al.  
 
Year: 
2014 
 
Citation: 
Chuke S.O., Yen N.T.N., 
Laserson K.F. et al. 
Tuberculin Skin Tests versus 
Interferon-Gamma Release 
Assays in Tuberculosis 
screening among immigrant 
visa applicants. Tuberculosis 
Research and Treatment, 
2014. ID 217969  
 
Aim of study: 
Prevalence of MTBI among 
immigrants 
 
Study design: 
Comparison of different tests 
 
Quality score: 
- 
 
Applicability: 
+ 
Source population(s): 
Migrants 
 
Eligible population: 
Vietnamese migrants to the 
US 
 
Selected population: 
Subjects were recruited on 
Wednesday among adults 
presenting for immigrant 
medical examinations at 
Cho Ray Hospital in Ho 
Chi Min City, Vietnam 
 
Excluded population: 
QTF-G not completed 
 
Setting: 
Clinic for immigrant 
medical examinations at 
Cho Ray Hospital in Ho 
Chi Min City, Vietnam 
 
Sample characteristics: 
Vietnamese adults who 
want to migrate to the US. 
- Mean age 38.8 y.o. 
- M:F = 67.6%:32.4%  
- 99.1% from Vietnam 
- TB symp 0.2% 
- BCG 41% 
- HIV +ve 0.6% 
- 12 positive sputum  
 
Sample size: 1246 
Method of allocation: 
None 
 
Intervention(s) 
description: 
Subjects were recruited on 
Wednesday among adults 
presenting for immigrant 
medical examinations at 
Cho Ray Hospital in Ho 
Chi Min City, Vietnam 
 
Blood samples for QTF 
and QTF-G taken before 
Mantoux (read 2-3 days 
later) 
 
Mantoux readers were 
blinded for QTF(-G) 
results 
Mantoux +ve >10 mm 
QTF(-G) interpreters 
blinded for other test 
results 
 
CXR suggestive of TB = 3x 
sputum for AFB and 
culture 
 
CXR were interpreted by 
physicians blinded for TST, 
QTF(-G) results but were 
aware of clinical findings 
 
Comparator/ control(s) 
description: 
CXR, Culture, smear 
 
Baseline comparisons: 
Nativity, gender, medical 
Hx, examination findings, 
HIV results, CXR findings, 
prior TB Hx (Rx, exposure, 
symptoms, BCG 
vaccination) 
Primary outcomes: 
Prevalence of MTBI 
 
Secondary outcomes: 
test agreement, PPV, NPV 
 
Method of analysis: 
PPV, NPV (predictive 
value statistic that utilized 
the Wald procedure). 
McNemar test to compare 
estimates of prevalence 
 
Agreement beyond chance 
was assessed using 
Cohen’s Kappa coefficient 
(𝜅𝜅 ) with a 𝜅𝜅 > 0.75  
representing excellent 
agreement,  0.40-0.75 
representing fair to good 
agreement, and <0.40 
representing poor 
agreement 
 
Hosmer-Lemeshow test 
 
Modelling method and 
assumptions: 
- Multivariate models were 
created using factors with 
values < 0.2   
- univariate analysis <0.05 
in stepwise logistic 
regression  
until the best fitting, 
parsimonious model was 
identified 
- No interactions between 
subject characteristics 
were considered to be of 
interest a priori. 
 
Time horizon: 
12 June 2002 – 12 March 
2003 
Primary results: 
This study demonstrated that 
substantially fewer adult 
immigrant applicants had 
evidence of TB on 
CXR (22%) than had a positive 
TST (57.9%) or a positive 
QFT-G (28.3%). 
 
Secondary results: 
Agreement between TST and 
QFT-G, CXR and TST, and CXR 
and QFT-G was poor 
 
Test agreement: 
- TST & QFT-G: 59.4% 
- CXR & TST: 50.1%  
- CXR & QFT-G: 63.5% 
Agreement beyond chance was 
poor.  
 
PPV: 
- TST + CXR: 25.9% (95% CI: 
22.6%-29.2%)  
- QFT-G + CXR: 25.6% (95% 
CI: 21.0%-30.1%)  
 
NPV: 
- TST + CXR: 83.8% (95% CI: 
80.5%-87.1%)  
- QFT-G + CXR: 79.8% (95% 
CI: 77.0%-85.6%) 
 
PPV for TST and QFT-G for a 
positive CXR were similar (p = 
0.87) but NPV for TST was 
greater than the NPV for QFT-G 
(p < 0.01). 
 
Neither TST nor QTF-G 
performed well as predictors of 
an abnormal CXR consistent with 
TB in this population (low PPV, 
high NPV). Too few cultures 
results were available to assess 
Limitations identified by 
author: 
- selection bias could have 
occurred due to restriction 
of enrollment to applicants 
presenting on Wednesday 
- recall bias 
(questionnaire) BCG 
vaccination (41% versus 
93.7% in population) 
 
Limitations identified by 
review team: 
- What was used as the 
gold standard 
- small number of culture 
positives 
- low % of sputum tests 
- statistical methods weak; 
not mentioned what 
confounders were inserted 
in the multivariate model 
 
Evidence gaps and/or 
recommendations for 
future research: 
All patients with a CXR 
suggestive of TB should 
have a sputum smear/ 
culture as well to use as 
gold standard 
 
Source of funding: 
CDC 
 
Conflict of interests: 
None 
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Study sufficiently 
powered?: 
Low number of sputum 
confirmed TB cases 
the sensitivity of TST or QTF-G 
for culture confirmed TB 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
Portugal 
 
Authors: 
Duarte R., Santos A., Mota 
M. et al.  
 
Year: 
2011 
 
Citation: 
Duarte R., Santos A., Mota 
M. et al. Involving 
community partners in the 
management of tuberculosis 
among drug users.Public 
Health. 2011;125: 60-62 
 
Aim of study: 
To evaluate the effect of the 
intervention on diagnosis of 
TB and Rx compliance 
 
 
Study design: 
Retrospective review of 
records 
Compare before and after 
intervention (2004) 
 
Quality score: 
- 
 
Source population(s): 
IVDU in Vila Nova de 
Gaia, Portugal 
 
Eligible 
population: 
IVDU in Vila Nova de 
Gaia, Portugal 
 
Population: 290,000 
 
Selected population: 
Screening and treatment 
records for all IVDU 
visiting Chest Disease 
Centre (CDP) between 
2001-2007 
 
Excluded population: 
NR 
 
Setting: 
All IVDU screened and 
treated at the outpatient 
TB clinic (Chest Disease 
Centre) 2001-2007 were 
reviewed 
 
Sample characteristics: 
Method of allocation: 
Before and after 2004 – 
intervention was 
implemented in 2004 
 
Intervention(s) 
description: 
Primary outcomes: 
Diagnosis of active TB, 
treatment compliance & 
abandonment before and 
after intervention 
 
Secondary outcomes: 
OR and 95% CI’s to 
measure association 
 
Method of analysis: 
OR and 95% CI’s 
 
Modelling method and 
assumptions: 
Improve early 
identification and 
treatment of drug users 
with TB 
Time horizon: 
2001-2003 intervention 
2005-2007 
Primary results: Limitations identified by 
author: 
- Not a controlled trial – 
risk for bias 
- What part of the 
intervention contributed 
more 
 
 
Limitations identified by 
review team: 
- Retrospective design = 
risk of bias 
- Methods not well 
described 
- What percentage did not 
come for screening (how 
many people recruited for 
screening) 
- Difference in time zone = 
risk for confounders, might 
have been on the political 
agenda, been on the news 
etc. = bias 
- low precise estimates of 
effects (indicated by wide 
95% CI’s) probably due to 
small sample size 
 
Evidence gaps and/or 
recommendations for 
future research: 
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Applicability: 
++ 
2001-2003: 
- 125 IVU @CDP  
- 52 screened (100% male, 
mean age 32 years) 
- 73 for sympt or following 
discharge with diagnosis 
TB 
 
2005-2007: 
- 465 screened (86% male, 
mean age 36 years) 
- 30 for sympt. or following 
discharge with diagnosis 
TB 
 
Study definitions: 
Active TB: culture M. 
tuberculosis or clinical & 
radiology criteria 
Latent TB:  asymptomatic 
individuals with normal 
chest radiography and 
positive TST (TST > 5 mm 
in immunocompromised 
persons, TST > 10 mm in 
immunocompetent 
persons). 
 
After 2003: 
Intervention to improve 
early identification and Rx 
of drug users with TB. 
 
The key partners 
(outpatient TB clinic, drug 
users support centres, 
shelters and street teams, 
local public health 
department and the local 
hospital) identified IVDU 
in their population 
- promotion of health-
seeking behaviour  
- notification card for 
screening in CDP 
- elimination of potential 
barriers: 
* street teams offered free 
transport 
*all  care at CDP free of 
charge  
- encouraged referral but 
tried to manage TB 
screening locally  
- seriously ill: immediate 
referral to CDP/local 
hospital (with transport 
and attendance. 
 
At CDP: 
- Screening: symptom 
questionnaire, TST & 
CXR: annual 
screening/after 
contact/symptoms 
- DOTS at CDP, combined 
with other medical Rx/ 
drug abuse Rx 
- CDP offered HIV testing 
in case of active TB 
 
Comparator/ control(s) 
description: 
2001-2003: 
- 125 IVU @CDP  
- 52 screened (100% male, mean 
age 32 years) 
- 73 for symptoms or following 
discharge with diagnosis TB 
*41.6% no symptoms 
*65.6% (82)active TB –13.4% 
(11) identified by screening 
*47.6% (39/82) poor compliance 
*35.4% (29/82) stopped Rx 
* 76.4% did not finish Rx 
correctly 
 
- Total TB cases in VNdG 2001-
2003: 515 – 15.9% (82) IVDU 
- Deaths: 32 – 15 IVDU (18.3% 
TB deaths among IVDU) 
- TB/HIV co-infection: 63 (71%) 
 
2005-2007: (after implementation 
of the programme)  
- 465 screened (86% male, mean 
age 36 years) 
- 30 for sympt or following 
discharge with diagnosis TB 
* 94% no symptoms 
*11.9% (59) active TB – 61% 
(36) identified by screening 
* 23.7% (14) poor compliance 
* 10.2% (6) stopped Rx 
*34.5% did not finish Rx 
correctly 
*13.6% died 
 
- Total TB cases in VNdG 2005-
2007: 386 – 15.3% (59) IVDU 
- Deaths: 19 – 8 IVDU (13.6% 
TB deaths among IVDU) 
- TB/HIV co-infection: 37 (64%) 
 
Conclusion:  
the number of screened drug 
users had increase, therapy was 
available to a higher proportion 
- Case-control trial to 
compare 2 different cities 
(one with intervention 
other without intervention 
- Check cost-effectiveness 
 
 
Source of funding: 
None 
 
Conflict of interests: 
None 
 
Ethical approval: 
Yes, approved by the CDP 
de Vila Nova de Gaia body 
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Before 2003:  
- IVDU referred to CDP 
with a diagnosis of TB 
after Dx from hospital  
– Rx was not compulsory 
– to improve compliance: 
info was provided, Rx of 
family, psychosocial 
support, full Rx, transport 
& free breakfast.  
- No active screening 
policy 
 
Baseline comparisons: 
Number of TB cases 
screened 
 
Study sufficiently 
powered: 
NR but wide 95% CI’s 
of TB cases and active TB 
treatment compliance had 
improved significantly  
 
Secondary results: 
- IVDU screened for TB without 
symptoms: OR 21.76; 95%CI 
13.03-36.33 
- IVDU with active TB: OR 10.1; 
95%CI 4.44-23.0 
- poor compliance: 
OR 0.34; 95%CI 0.16-0.72 
- Rx stopped 
OR 0.21; 95%CI 0.08-0.54 
- %IVDU under TB cases OR 
0.95; 95%CI 0.66-1.37 
- TB deaths among IVDU OR 0.7; 
95%CI 0.28-1.78 
-TB/HIV co-infection OR 1.37; 
95%CI 0.68-2.78 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
USA 
 
Authors: 
George S.A., Ko C.A., 
Kirchner H.L. et al. 
 
Year: 
2011 
 
Citation: 
George S.A., Ko C.A., 
Kirchner H.L. et al. The rol 
of chest radiographs and 
tuberculin skin test in 
tuberculosis screening of 
internationally adopted 
children. 
Source population(s): 
Migrant children  
 
Eligible population: 
Internationally adopted 
children (IAC) entering the 
US 
 
Selected population: 
Asymptomatic IAC at the 
Adoption Health Services 
(AHS) of Rainbow Babies 
and Children Hospital in 
Cleveland, Ohio. 
TST done within 6 months 
of arrival in the US 
 
Excluded population: 
Method of allocation: 
NA 
 
Intervention(s) 
description: 
- Chest X-rays to rule out 
pulmonary TB when TST 
indurations are >5 mm but 
treat for LTBI when TST 
indurations are >10 mm. 
- TST <5 mm within 3/12 
of arrival need repeat TST 
at 6/12 if false negatives 
due to malnutrition 
- CXR was marked: 
normal, abnormal but not 
TB or TB 
 
Primary outcomes: 
To evaluate the clinical 
usefulness of using a 5-mm 
TST cut point as 
the threshold beyond which 
further chest radiographic 
screening for TB disease is 
done in asymptomatic IAC 
 
Secondary outcomes: 
the relationship between 
documented chest 
radiograph readings and 
TST indurations in IAC 
 
Method of analysis: 
- frequency and 
percentages for 
Primary results: 
No indication to complete chest 
radiographs in IAC with 
5mm<TST<10mm 
as this TST induration range does 
not identify a group of children 
with increased risk for LTBI or 
progression to TB.  
 
- 35% (193 of 544) had TST 
induration>5 mm 
- 103 children (53.4%) had 
5mm<TST<10mm and 90 
children (46.6%) had TST>10 
mm 
- Normal CXR in 71.8% and 
78.9% 
- 1% (1 of 103) of the group with 
Limitations identified by 
author: 
- Subjectivity of CXR 
reading for TB 
 
Limitations identified by 
review team: 
Potential important 
confounders are not 
considered; BCG 
vaccination status, socio-
economic status 
 
HAZ could as well be 
caused by the outcome 
(active TB); I think it may 
lie in the causal pathway 
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Pediatr Infect Dis J 
2011;30:387-391 
 
Aim of study: 
To examine the clinical 
utility of tuberculin skin 
testing (TST) and subsequent 
chest radiograph screening 
for TB disease in recently 
immigrated, 
asymptomatic 
internationally adopted 
children 
 
Study design: 
Prospective cross-sectional 
study 
 
Quality score: 
+ 
 
Applicability: 
- 
Incomplete documentation 
(3.9%) 
 
Setting: 
Adoption Health Services 
(AHS) of Rainbow Babies 
and Children Hospital in 
Cleveland, Ohio 
 
Sample characteristics: 
Children from Russia, 
China, Guatemala and 
other countries 
Size: 566 
Comparator/ control(s) 
description: 
Other TST induration 
groups 
 
Baseline comparisons: 
TB diagnosis 
 
Study sufficiently 
powered?: 
No, small group of CXR’s 
categorical variables 
- mean, standard deviation, 
and range for  continuous 
variables 
- comparison between TST 
induration groups Pearson 
_2 statistic and analysis of 
variance (ANOVA) 
- Multiple logistic 
regression was used to 
investigate the relationship 
between TST induration 
and demographic 
and birth characteristics. - 
odds ratios (ORs) & 95% 
confidence intervals 
(CIs). 
 
Modelling method and 
assumptions: 
Multivariate regression 
using predefined co-
variates sex, age, country 
of origin and HAZ. No 
other confounders 
considered.  
 
Time horizon: 
between August 2000 and 
June 2009 
5mm<TST<10 mm had CXR’s 
that were “Abnormal, Consistent 
with TB” compared with 3.3% (3 
of 90) of those with 
TST>10 mm.  none had final 
diagnosis TB 
- Both groups had 6 children with 
abnormal CXR not TB 
- 29 children had CXR done 
somewhere else = no result (21 vs 
8) 
- 3 children had no CXR done (1 
vs 2) 
 
Secondary results: 
- There were insufficient counts to 
assess the association between 
radiographic results and TST 
induration groups, gender, or 
birth country 
 
- Children with a TST induration 
>10 mm were older 
-  Children with TST induration 
>10 mm were more stunted 
(chronically malnourished) – no 
association with stunting 
(severely malnourished, demised 
immune responds) 
- birth country was associated 
with TST>10 mm (p= 0.0228)  
Guatemala and Russia were kore 
than 2x more likely to have TST 
>10 mm (?bias due to large 
group or BCG variant used in 
these countries) 
No information on 
potential bias due to 
missing data 
 
Evidence gaps and/or 
recommendations for 
future research: 
Larger study needed, with 
more information on 
important confounders 
 
 
Source of funding: 
NR 
 
Conflict of interests: 
NR 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
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Country: 
Italy 
 
Authors: 
Girardi, E., Palmieri F, 
Angeletti C. et al. 
 
Year: 
2012 
 
Citation: 
Girardi, E., Palmieri F, 
Angeletti C. et al., Impact of 
previous ART and of ART 
initiation on outcome of 
HIV-associated tuberculosis. 
Clinical & Developmental 
Immunology, 2012. 2012: p. 
931325 
 
Aim of study: 
To estimate the impact of 
cART on TB outcome 
 
Study design: 
Multicenter, prospective, 
observational study 
 
Quality score: 
+ 
 
Applicability: 
+ 
Source population(s): 
HIV infected individuals 
 
Eligible population: 
HIV infected individuals in 
Italy 
 
Selected population: 
HIV infected individuals 
presenting to one of the 96 
Italian hospitals 
- >18 years of age  
- confirmed HIV infection 
- diagnosed with 
tuberculosis 
 
Excluded population: 
NR 
 
Setting: 
HIV +ve patients 
diagnosed with TB 
presenting to Infectious 
disease hospitals in Italy 
 
Sample characteristics: 
- 271 HIV-infected patients  
- M:F = 199:47 
- 48% intravenous drug 
users 
- 34% foreign born  
 
- 25 (9.22%) did not start 
tuberculosis treatment (5 
transferred-out and 20 lost 
to follow up immediately 
after diagnosis) 
- 246 patients included 
- 80.2% male  
- median age: 36.9 years 
(21.27–76.03) 
- 160 culture confirmed TB 
(22 DR-TB, 4 MDR-TB) 
 
- Median time from first 
Method of allocation: 
NA 
 
Intervention(s) 
description: 
The effect of cART on TB 
outcome  
 
Comparator/ control(s) 
description: 
cART naïve 
 
Baseline comparisons: 
TB outcome, (success, 
failure, death) 
 
Study sufficiently 
powered?: 
NR 
Primary outcomes: 
The impact of cART on TB 
outcome 
 
Secondary outcomes: 
The impact of use of cART 
during TB treatment on 
death rate of HIV-infected 
patients with TB 
 
Method of analysis: 
- Descriptive statistical 
methods 
- χ2 or Fisher’s Exact Test, 
as appropriate, were used 
to compare proportions.  
- Odds ratios (ORs) with 
the associated 
95% confidence intervals 
(CI) were calculated to 
measure the association 
between variables and 
treatment outcome 
 
Modelling method and 
assumptions: 
- Polytomous logistic 
regression, we analyzed 
association of baseline 
characteristics associated 
with outcome 
- Poisson regression to 
investigate the impact of 
cART on mortality rate -
presented as mortality rate 
ratios + 95% CI’s 
Time horizon: 
NR – 15 month period 
Primary results: 
TB treatment outcome: 
- 130/246 (52.8%) successful – 75 
(30.5%) cured & 55 (22.4%) 
completed treatment 
- 80/246 (32.5%) unsuccessful 
outcome – 44 (17.9%) LoF in a 
median time of 1 month, 25 
(10.2%) defaulters, 9 (3.7%) 
transferred out, 2 (0.8%) faulures 
- 36/246 (14.6%) died a median 
time of 2 months after starting TB 
treatment 
 
Multivarianle polytomous logistic 
regression:  
- not being ART-naïve was 
associated with an increased 
probability of unsuccessful 
outcomes 
-  foreign born was associated 
with a 3x increase of the 
risk of unsuccessful outcomes 
(OR: 3.38, 95% CI: 1.38–8.29, 
p =  0.008) 
- also for IVDU 
 
Risk of death associated with: 
- IVDU 
- lower CD4 count at time of TB 
diagnosis 
- MDR-TB 
 
cART during TB treatment: 
- 151 (61.4%) received cART and 
TB treatment concurrently 
* 62 were already on cART at TB  
diagnosis (median of 24 months 
on ART) 
* 89 started cART during TB 
treatment:  56 (62.9%) in the 
initial phase and 33 (37.1%) in 
the continuation phase 
- 21 patients were not ART-naive 
but not on ART at TB diagnosis 
Limitations identified by 
author: 
- No clinical details to 
evaluate severity 
of TB in patients 
- Couldn’t determine if 
ART-naive had virological 
treatment failures and/or 
antiretroviral resistance at 
the time of tuberculosis 
diagnosis 
- high % of patients 
abandoned treatment may 
have affected the analysis 
of factors associated with 
death 
- study was conducted on 
patients treated relatively 
early in the cART era, and 
thus the conclusions on the 
effect on new cART 
regimens may not 
necessarily be applicable 
 
Limitations identified by 
review team: 
Harms, like IRIS, side 
effects of cART etc not 
assessed 
 
Evidence gaps and/or 
recommendations for 
future research: 
- Include history of failing 
to adhere to cART 
- TB history to be included 
- A study to examine the TB 
prevention due to cART 
 
Source of funding: 
Italian Ministry of 
Health-Progetto AIDS 
 
Conflict of interests: 
NR 
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date of HIV 
seropositivity was 36.9 
months (0–201.3) 
- 96  (39%) were not ART-
naive at the time of TB 
diagnosis 
*  34 received ART for a 
median of 13.5 months (1–
86), not in the 3 months 
preceding TB diagnosis  
* last ART regimen 
included a PI in 20 
patients and a NNRTI in 11 
patients 
-  Baseline median CD4 
count: 
120.5/mmc (0–1111) 
- median VL (calculated 
in 241 patients): 4.94 log 
copies/mL.  
- At least 1 AIDS defining 
illness disease was 
recorded in 60 (24.4%) 
patients 
 
 
 
Secondary results: 
-36 deaths of the 161.2 person-
years (PY) observed = an overall 
mortality rate of 22.3 per 
100 PY (95% CI: 16.1–31.0).  
- 17/36 were not ART-naive 
- 7/36 were ART-naive and 
started cART during TB treatment 
- 12/36 never started cART. 
 
Multivariable analysis  
- cART during TB treatment 
significantly reduced the risk 
of death (IRR 0.14, 95% CI 0.06–
0.30, p <  0. 001) 
- not being ART-naive at TB 
diagnosis > 4x increase in the 
same risk (IRR 4.04, 95% CI 
1.09–14.96, p = 0.037) 
 
Risk of death was associated 
with: 
- lower CD4 cell count 
- age ≥  40 at diagnosis 
- MDR-TB 
 
 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods of 
analysis 
Results Note by review team 
Country: 
Germany (Frankfurt/Main) 
 
Authors: 
Goetsch U., Bellinger O.K., 
Buettel K.L., Gottschalk R.   
 
Year: 
2012 
 
Source population(s): 
Homeless & IVDU 
 
Eligible population: 
Homeless & IVDU 
recruited from homeless 
and drug services in 
Frankfurt/Main 
 
Selected population: 
Method of allocation: 
NA 
 
Intervention(s) 
description: 
Community health worker 
educated staff and users at 
services for homeless and 
IVDU about TB 
transmission and promoted 
Primary outcomes: 
Feasibility and 
sustainability of a TB 
programme focussing on 
TB education and 
voluntary X-ray 
investigation in homeless 
and IVDU 
 
Secondary outcomes: 
Primary results: 
It is feasible when included in 
already existing public health 
services 
 
Secondary results: 
Limitations identified by 
author: 
- selection bias, illegal 
immigrants might avoid 
authorities 
- small number of TB 
patients makes it difficult 
to say anything about age 
and gender differences 
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Citation: 
Goetsch U., Bellinger O.K., 
Buettel K.L., Gottschalk R.   
Tuberculosis among drug 
users and homeless persons: 
impact of voluntary X-ray 
investigation on active case 
finding 
Infection;2012:40:389-395 
 
Aim of study: 
To evaluate the  feasibility 
and sustainability of the 
program, its coverage 
and both the case-finding 
rates and characteristics of 
cases. Also to  assess the 
treatment outcomes 
 
Study design: 
Before and after comparison 
 
Quality score: 
- 
 
Applicability: 
+ 
All subjects seen at the 
Public Health Department 
for CXR and fulfilled the 
criteria for homeless 
(stayed at shelter for >2 
nights) /IVDU (attend day-
care facilities, night shelter 
for IVDU or needle 
exchange programme)  
 
Excluded population: 
Patients with TB symptoms 
detected in clinics and 
were notified throught the 
Protection against 
Infection Act 
 
Setting: 
CHW went to services to 
promote CXR – CXR 
performed at Public Health 
Department 
 
Sample characteristics: 
4529 CXR’s in 3477 people 
- 66% homeless 
- 34% IVDU 
 
Homeless: 
- 40.9 years ± 12.5 years 
- 90.1% male 
- 29.65 foreign born 
 
IVDU: 
- 35.8 years ±8.3 years 
- 76.2% male 
- 28% foreign born 
(increased over study 
period  2002: 15%, 
2007:37%) 
 
voluntary CXR at Public 
Health Department 
1x/year or at least 
1x/2years 
 
Community Health Worker 
obtained the medical 
history through 
standardised questionnaire 
 
CXR read by TB physician 
– referral and F/U test in a 
clinic could be initiated 
immediately 
 
Suspicion for active TB – 
CHW took care of further 
diagnostics and F/U 
Active TB needed 
hospitalisation for Rx 
 
CHW kept contact with 
doctors/social workers 
2x/month later monthly 
Contact tracing in shelter 
 
HIV was only notified in 
active TB patients 
 
Comparator/ control(s) 
description: 
Before intervention – no 
CHW who gave TB 
education and promoted 
CXR 
 
Baseline comparisons: 
Coverage of CXR 
screening before and after 
intervention 
 
Study sufficiently 
powered?:  
Low number of active TB 
cases 
Estimate the coverage of 
the programme, assess 
other risk factors and 
determine TB rates & Rx 
outcome in these 2 groups 
 
Method of analysis: 
- t-test or analysis of 
variance for continuous 
variables 
- chi-square test or 
Fisher’s exact test for 
categorical data 
 
Modelling method and 
assumptions: 
- Multivariate logistic 
regression effect of risk 
groups, birth place, age & 
gender  
 
Time horizon: 
1 May 2002- 30 April 2007 
- No. CXR: 10/month in homeless 
& 9/month in IVDU 
After intervention 46/month in 
homeless & 25/month in IVDU 
 
-Coverage: screening 1x/2 years: 
18% of IVDU& 26% of homeless 
and 10% and 15% every year 
(based on IVDU & homeless 
group between 6416 and 9,000 in 
Frankfurt/Main) 
- Chao’s heterogeneity model: 
18-26.3%  
1CXR/2 years (2002-2004: 
18.0%, 2003-2005: 19.3%, 2004-
2006: 26.4%, 2005-2007: 23.4%) 
and 10-15%  CXR/year (2002-
2004: 10.0%, 2003-2005: 10.7%, 
2004-2006: 15.0%, 2005-2007: 
23.4%) 
 
- Case finding: 
39 TB cases in 5 years: 14 IVDU 
& 25 homeless 
= 8.7% of total TB cases in 
Frankfurt 
19 cases smear +, 7 smear –ve 
but culture +ve, 13 cases 
clinical/radiological diagnosis 
- case finding rate 861/100 000 
CXR’s 
- IVDU 10/14 HIV+ve, homeless 
1/25 HIV+ve 
- 76.3% (29/38) completed Rx 
*5 needed admission because of 
non-compliance (3IVDU, 2 
homeless) 
- 5 died of other causes than TB 
(3 homeless and 2 IVDU) 
- 4 stopped Rx (lack of 
compliance) – 10.5% 
- No difference in Rx outcome 
between IVDU & homeless 
- no data on length of 
IVDU and homelessness 
- the impact of HIV can’t 
be estimated 
- unknown fluctuations of 
the study population make 
the denominator unstable 
 
Limitations identified by 
review team: 
- Patients had to travel to 
the public health 
department 
- selection bias as it is 
voluntary and therefor not 
everyone comes to the 
screening, maybe only the 
sick ones 
- comparison over time, 
important confounder 
- not adjusted for distance 
from service to public 
health department 
 
Evidence gaps and/or 
recommendations for 
future research: 
Use a control group and 
use mobile CXR unit to 
increase screening 
 
 
Source of funding: 
NR 
 
Conflict of interests: 
None 
29 
 
- No difference in foreign borne 
or nationals (selection bias – 
avoid authorities) 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
Norway 
 
Authors: 
Harstad I., Henriksen A.H., 
Sagvik E. 
 
Year: 
2014 
 
Citation: 
Harstad I., Henriksen A.H., 
Sagvik E. Collaboration 
between municipal and 
specialist public health care 
in tuberculosis screening in 
Norway. BMC Health 
Services Research.2014; 
14:238 
 
Aim of study: 
Improve follow-up of 
patients with positive TB 
screening results through 
intervention that included 
increasing the collaboration 
between municipal and 
specialist public health care 
and new routines for 
summoning patients 
 
Study design: 
Non-randomized study 
comparing before-and-after 
intervention 
Source population(s): 
People living in the Sor-
Trondelag county who 
underwent TB screening at 
the 2 public health services 
 
Eligible population: 
Patients with positive TB 
screening referred to local 
TB clinic 
 
Selected population: 
All patients referred from 
the 2 public health centres 
to the TB clinic between 
Sep 2009 and June 2012 
 
Excluded population: 
Patients with alarming 
symptoms or grossly 
abnormal X-rays 
 
Setting: 
Patients suspected of TB 
referred to the Pulmonary 
Out-patient Department 
(POPD) of the St. Olavs 
University Hospital, 
Trondheim, Norway 
 
Sample characteristics: 
VICO (1st public health 
centre) 
134 control group 
- 30 contact tracing 
Method of allocation: 
Time based: Inclusion 
controls: September 2009 
– August 2010 for VICO; 
October 2010 – April 2011 
for RHC 
Inclusion intervention: 
July 2011 – June 2012 for 
VICO; September 2011 – 
June 2012 for RHC  
 
Intervention(s) 
description: 
Migrants in Norway are 
screened by Mantoux, 
followed by CXR ± IGRA.  
In the old system they 
received a letter for follow-
up appointment 
 
2 problems identified: 
- high rate of no show  
- long time between 
screening and appointment 
 
Main intervention:  
1. change practice of  
summoning patients for 
follow-up 
- letters 
- patient contacted by 
phone, directly, through a 
contact person, or through 
a translator. 
Primary outcomes: 
- Frequency of patients 
who attended their first 
consultation at the TB 
clinic 
- The time from screening 
in the municipality to 
examination at the TB 
clinic 
 
Secondary outcomes: 
- Final attendance 
 
Method of analysis: 
Frequencies with 
proportions and 95% 
confidence intervals 
  
Modelling method and 
assumptions: 
Medians compared across 
independent groups by 
non-parametric test 
(Mann-Whitney test) using 
Median Test for k samples  
p < 0.05 statistically 
significant 
 
Primary results: 
Attendance increased from: 
-  97/134 (72%) to 109/123 (89%) 
in VICO 
- 28/46 (61%) to 55/59 (93%) in 
RHC 
 
Time from screening to 
examination at the hospital 
reduced from:  
- median 30 to 10 weeks in VICO 
(p < 0.001)  
- median 15 to 8 weeks in RHC (p 
= 0.04). 
 
Secondary results: 
Final attendance increased from: 
- VICO 115/134 (86% [95% CI 
80–92%]) to 115/123 (93% [95% 
CI 89–98%])  
- RHC 44/46 (96% [95% CI 90–
100)%] to 58 (98% [95% CI 95–
100%])  
 
Attendence at first consultation 
increased from: 
- VICO 97/134 (72% [95% CI 
65-80%]) to 109/123 (89% [95% 
CI 83-94]) 
RHC 28/46 (61% [95% CI 47-
75%]) to 55/56 (93% [95% CI 
87-100%]) 
Limitations identified by 
author: 
- For the control group: 
information was not 
available at the 
municipality it was 
retrieved from the hospital: 
data could be missing or 
registered in a different 
way at different levels = 
risk of bias 
- Yearly differences in 
patients’ country of origin 
 
Limitations identified by 
review team: 
- Sparse reporting of 
results 
- No description or 
adjusting for possible 
confounders (country of 
origin) 
- Small sample size 
 
Evidence gaps and/or 
recommendations for 
future research: 
Adjust for country of 
origin, large sample size 
 
Source of funding: 
The Central Norway 
regional Health Authority 
funded the project. 
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Quality score: 
- 
 
Applicability: 
+ 
- 47 family reunion 
- 19 labour migrants 
- median 30 y.o. (16-74) 
- 82 females (61% - 95% 
CI 53-69%) 
 
Countries of origin 
- 49 different countries 
- 30 Norway 
- 11 Philippines 
- 10 China 
 
123 intervention group 
- 38 family reunion 
- 16 contact tracing 
- 28 labour migrants 
- 13 students 
- median age 29 y.o. (19-
77) 
- 86 females (70% - 95% 
CI 62-78%) 
Country of origin 
- 42 different countries 
- 20 Philippines 
- 15 Norway 
- 8 Vietnam 
 
Higher % of LTBI in 
intervention group 
 
RHC (2nd public health 
centre) 
- asylum seekers 
- refugees 
46 in control group: 
15 different countries 
- 12 Eritrea 
- 10 Somalia 
- 4 Liberia 
- 3 Ethiopia 
- median age 28,5 y.o. (17-
59) 
- 19 female (41%- 95% CI 
27-56%) 
 
2. - Change timing of the 
tests to reduce number of 
tests done at POPD 
appointment 
- Reduce number of blood 
samples drawn 
 
Comparator/ control(s) 
description: 
Same population, pre-
intervention (retrospective 
record check) 
 
 
Baseline comparisons: 
Effect of intervention by 
comparing pre- and post-
intervention 
 
Study sufficiently 
powered?: 
Not described 
Time horizon: 
September 2009 – June 
2012 
 
VICO (1st public health 
centre) 
Controls: Sep. 2009- Aug. 
2010 
Intervention group: July 
2011-June 2012 
 
RHC (2nd public health 
centre) 
Controls: Oct. 2010-April 
2011 
Intervention group: Sep. 
2011-June 2012 
 
 
Conflict of interests: 
None declared 
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59 in intervention group: 
12 different countries 
- 20 Somalia 
- 8 Ethiopia 
- 6 Afghanistan 
- 6 Eritrea 
- 6 Myanmar 
- median age 27 y.o. (16-
71) 
- 29 females (49%- 95% CI 
36-62%) 
 
 
Study details Population and setting Intervention/comparator Outcomes and methods of 
analysis 
 
Results Note by review team 
Country: 
UK 
 
Authors: 
Jit M. Stagg H.R., Aldridge 
R. et al. 
 
Year: 
2011 
 
Citation: 
Jit M. Stagg H.R., Aldridge 
R. et al. Dedicated outreach 
service for hard to reach 
patients 
with tuberculosis in London: 
observational study and 
economic evaluation. BMJ 
2011;343:d5376 
 
Aim of study: 
To assess the cost 
effectiveness of the Find and 
Treat service for diagnosing 
and managing hard to reach 
individuals with active 
tuberculosis in London 
Source population(s): 
Hard to reach individuals 
 
Eligible population: 
Hard to reach individuals 
with active pulmonary 
tuberculosis 
 
Selected population: 
Hard to reach individuals 
with active pulmonary 
tuberculosis screened or 
managed by the Find and 
Treat service 
 
Excluded population: 
- cases of extrapulmonary 
tuberculosis 
-  latent tuberculosis 
- suspected tuberculosis 
- cases merely receiving 
prophylaxis (and hence 
unlikely to have active 
tuberculosis) 
- cases for which the 
diagnostic delay could not 
be calculated 
Method of allocation: 
NA 
 
Intervention(s) 
description: 
All individuals are 
screened on voluntary 
basis.  
1. Mobile screening clinic 
X-ray visited locations 
where high risk groups 
could be found (homeless 
shelters, drug treatment 
centres, criminal services, 
street outreach etc.) 
2. raise awareness 
3. under take case holding 
4. provide support for 
treatment completion 
(supported by peer 
workers) 
 
Comparator/ control(s) 
description: 
Controls:  passively 
detected control cases with 
active pulmonary 
Primary outcomes: 
Incremental costs, quality 
adjusted life years  
(QALYs), for the Find and 
Treat service. 
 
Secondary outcomes: 
cost effectiveness ratios for 
the Find and Treat service 
 
Method of analysis: 
NR 
 
Modelling method and 
assumptions: 
- discrete, multiple age 
cohort, compartmental 
model to model a 
population of individuals 
with active tuberculosis 
 
4 groups: 
- active untreated 
tuberculosis 
- active treated 
tuberculosis with 
up to 125 days of 
Primary results: 
The model estimated that, on 
average, the Find and Treat 
service identifies 16 and manages 
123 active cases of tuberculosis 
each year in hard to reach groups 
in London. The service has a net 
cost of 
£1.4 million/year and, under 
conservative assumptions, gains 
220 
QALYs. The incremental cost 
effectiveness ratio was £6400-
£10,000/QALY gained (about 
€7300-€11,000 or $10,000-
$16,000 in September 2011).  
 
- 22.9% of patients detected by 
the mobile screening unit with the 
longest delays between symptom 
onset and treatment presentation 
were unlikely to present for 
treatment without the activities of 
the Find and Treat service 
-  35.4% of mobile screening unit 
patients were asymptomatic on 
detection, and hence would not 
Limitations identified by 
author: 
- absence of a trial 
randomising tuberculosis 
cases to be either managed 
or not 
managed by the Find and 
Treat service 
-  the service also 
manages extremely hard to 
reach individuals, who are 
often already lost to 
follow-up at the time of 
referral or who would 
never present for care 
without the mobile 
screening unit.  Hence 
the comparison of cases 
with retrospective controls 
probably underestimates 
the incremental benefit of 
the service, although we 
cannot be certain without a 
randomised study 
- did not incorporate 
secondary transmission 
into the economic 
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Study design: 
Economic evaluation using a 
discrete, multiple age 
cohort, 
compartmental model of 
treated and untreated cases 
of active 
tuberculosis. 
 
Type of economic analysis: 
Cost-effectiveness 
 
Economic perspective: 
healthcare taxpayer 
perspective 
 
Internal validity: 
Yes 
 
Quality score: 
+ 
 
Applicability: 
+ 
- cases younger than 16 
years 
 
Setting: 
London, United Kingdom. 
 
Sample characteristics: 
- 48 mobile screening unit 
cases 
- 188 cases referred for 
case management support 
- 180 cases referred for 
loss to 
follow-up 
- 252 passively presenting 
control cases 
 
Economic analysis data 
source: 
Find and Treat database 
for information (including 
risk factors and clinical 
information) of individuals,   
diagnosed with PTB 
(between Sep 2007- Sep 
2010) 
 
Passive cases from the 
Health Protection Agency 
between Jan 2009 and Aug 
2010. 
Risk factors and clinical 
information for the 
controls were obtained 
from the enhanced 
tuberculosis surveillance 
system. 
tuberculosis (individuals 
who presented to London 
tuberculosis services of 
their own accord without 
screening and referral to 
the Find and Treat service 
- notified to the Health 
Protection Agency’s 
enhanced tuberculosis 
surveillance system 
between 1 January 2009 
(when the system began 
recording risk factor 
information) and 9 
August 2010. 
Controls were age 
matched with actively 
detected cases (within five 
year age categories) and 
that displayed one or more 
risk factors (a history of 
homelessness or 
imprisonment, drug or 
alcohol abuse, or mental 
health problems). 
 
Baseline comparisons: 
Compared:   
- having no Find and Treat 
service, 
- having only one part of 
the service (the mobile 
screening unit or the 
case management 
component) 
- having both parts of the 
service 
 
Study sufficiently 
powered: 
NR but a small number of 
PTB cases in the Find and 
Treat group 
continuous treatment 
- active treated 
tuberculosis with more 
than 125 days of 
continuous treatment 
- lost to follow-up 
 
4 final outcomes (from 
which they do not leave):  
- completion of treatment 
- death due to tuberculosis 
related causes 
- death due to other causes 
- other final outcomes that 
the Find and Treat service 
is not expected to change 
(such as patients being 
transferred out of London 
or stopping treatment for 
clinical reasons). 
 
Assumptions: 
- the cost of a new mobile 
unit £600 000 were added 
to the costs of the first year 
of the service, with 
discounted costs and 
outcomes totalled over five 
years 
- costs of 
£8300 and £75000 for 
treatment of DS-TB and 
MDR-TB 
- only 50% of 
asymptomatic cases with a 
positive result from the 
mobile screening unit 
would progress to 
symptomatic disease 
- Find and Treat cases 
would be lost to follow-up 
at the same rate as 
enhanced tuberculosis 
surveillance controls 
(17.2% per year) in the 
have presented for treatment 
without the unit. 
-  Once on treatment, mobile 
screening unit cases managed by 
the Find and Treat service had a 
much lower risk of loss to follow-
up than passively presenting 
controls (loss to follow-up 
probability after one year: 2.1% 
for cases, 17.2% for controls) 
- cases referred to Find and Treat 
because of complex case 
management issues had higher 
rates of completing treatment 
(61.2% after one year) and lower 
rates of loss to follow-up (3.3% 
after one year) than controls 
 
Secondary results: 
-  every year the service has a net 
cost of £1.4 
million and gains 220 QALYs 
-  Incremental cost effectiveness 
of the Find and Treat service was 
£6,400/QALY gained 
- both components of the service 
are cost-effective at the same 
threshold. The mobile screening 
unit had an incremental ratio of 
£18,000/QALY gained, whereas 
the case management component 
had an incremental ratio of 
£4,100/QALY gained (In the most 
unfavourable (and highly 
unlikely) scenario, 
which combined all the 
unfavourable assumptions, the 
mobile screening unit and case 
management components had 
incremental ratios of 
£26,000/QALY gained and 
£6,800/QALY 
gained, respectively) 
 
0.5% of mobile screening unit 
evaluation, even though 
the mobile screening unit 
in particular probably 
averts several secondary 
cases by finding highly 
infectious individuals. 
- did not measure the effect 
of the Find and Treat 
service on reducing the 
likelihood of patients 
developing and 
transmitting acquired drug 
resistance (as a result of 
poor treatment adherence).  
Drug resistance increases 
the duration and costs of 
treatment, as well as the 
risk 
of severe disease, thus 
prevention could be an 
important benefit of the 
service. 
 
Limitations identified by 
review team: 
Small group of PTB in 
intervention group 
 
Evidence gaps and/or 
recommendations for 
future research: 
Include a larger 
intervention group, longer 
follow up study 
 
Source of funding: 
grant from the English 
Department of Health  
grant reference number 
0150305 
 
PJW was partly funded by 
centre funding from the 
Medical Research 
Council. IA and HS are 
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absence of the service, 
rather than at the higher 
rate we estimated for this 
extremely hard to reach 
group (34.7% per year). 
- even without Find and 
Treat involvement, these 
cases could still passively 
re-engage with treatment at 
the same rate as enhanced 
tuberculosis surveillance 
controls (51% per year). 
 
Time horizon: 
Sep 2007 – July 2010 
patients and 5.3% of other Find 
and Treat patients had multidrug 
or extensively drug resistant 
infection 
partly funded by the 
National Institute for 
Health 
Research. 
 
Conflict of interests: 
None 
 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
US 
 
Authors: 
Lowenthal P., Westenhouse 
J., Moore M. et al. 
 
Year: 
2011 
 
Citation: 
Lowenthal P., Westenhouse 
J., Moore M. et al. Reduced 
importation of tuberculosis 
after the implementation of 
an enhanced pre-migration 
screening protocol. Int J 
Tuberc Lung Dis 15(6);761-
766 
 
 
Aim of study: 
Source population(s): 
Migrants 
Eligible population: 
California-bound 
immigrants  
 
Selected population: 
California-bound 
immigrants from Mexico, 
Phillipines and Viet Nam 
with suspected TB 
classification 
 
TB diagnosis within 6 
months of arrival 
 
Excluded population: 
Immigrants were excluded 
if they moved out of 
California prior to 
evaluation. 
 
Method of allocation: 
Everyone who wants to 
immigrate to the US from 
Mexico, Phillipines and 
Viet Nam 
 
Intervention(s) 
description: 
Culture for all suspected 
CXR’s, symptoms for TB 
and HIV+ & DOTS 
 
Comparator/ control(s) 
description: 
Pre-intervention, Mexico 
& Philippines: October 
2006-September 2007 
Viet Nam February -
September 2007 
 
Baseline comparisons: 
Primary outcomes: 
TB case detection among 
immigrants in the US 
within their first 6 months 
of arrival 
 
Secondary outcomes: 
Comparison between 
countries 
 
Method of analysis: 
Chi-square test and 
Fisher’s exact test to 
compare proportions 
 
The Wilcoxon rank sum 
test was used to compare 
differences between 
medians 
 
Modelling method and 
assumptions: 
Primary results: 
The proportion of immigrants 
identified in California with TB 
disease within 6 months of arrival 
decreased from 4.2% (86 cases) 
in the pre-intervention cohort to 
1.5% (22 cases) in the post-
intervention cohort. 
 
The only statistically significant 
decrease in cases was among 
immigrants originating from the 
Philippines (P<0.001) 
 
- case frequency did not decline 
among immigrants originating 
from countries where prei-
mmigration screening was not 
modified 
 
Secondary results: 
Philippines contributing the 
Limitations identified by 
author: 
- Observational design 
- small number 
- limited to 3 countries 
- first year after 
implementation 
 
Limitations identified by 
review team: 
- short follow up time (only 
6 months) 
- we do not know how 
many extra cases were 
picked up by this 
intervention (but it was 
said it was not significant) 
- big size difference in the 
2 comparison groups 
- No estimation of the 
effect nor adjustment for 
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to determine whether TB 
disease importation 
has decreased following the 
intervention of adding 
sputum cultures for people 
with abnormal CXR, symp of 
TB or HIV+ to the screening 
protocol 
and if the intervention 
reduced the frequency of 
infectiousness 
(e.g., smear-positive and 
culture-positive) 
among persons with 
imported TB 
 
Study design: 
Retrospective, observational, 
comparison, before after 
intervention 
 
Quality score: 
+ 
 
Applicability: 
+ 
Setting: 
Importation of infectious 
tuberculosis (TB) 
threatens TB control in 
California and the United 
States 
 
Sample characteristics: 
California-bound 
immigrants from Mexico, 
Phillipines and Viet Nam  
2/3 >45 y.o. 
Size: 3479 
% development of active 
TB in first 6 months in US 
 
Study sufficiently 
powered? 
Seems large enough but 
small number of TB cases 
in immigrants from Mexico 
and Viet Nam - ?lower TB 
incidence in these 
countries than in the 
Philippines 
No multivariate model 
used 
 
Time horizon: 
October 2006 – March 
2009 
 
largest fraction of cases, followed 
by Viet Nam, then Mexico 
 
The median time from pre-
migration evaluation to US 
arrival increased significantly, 
from 
81 days (interquartile range 
[IQR] 53–117) in the pre-
intervention cohort to 112 days 
(IQR 98–133, 
P=0.005) in the post-intervention 
cohort. 
 
A smaller proportion of cases in 
the post-intervention cohort had 
either a positive AFB sputum 
smear or a positive M. 
tuberculosis sputum culture, but 
the differences were not 
statistically significant 
confounders in a 
multivariate model 
 
Evidence gaps and/or 
recommendations for 
future research: 
- Comparable group sizes 
- add numbers picked up in 
these countries 
- add logistic regression 
analysis to estimate the 
effect measure 
 
Source of funding: 
NR 
 
Conflict of interests: 
NR 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
US 
 
Authors: 
Liu Y., Posey D.L., Cetron 
M. S. et al. 
 
Year: 
2015 
 
Citation: 
Liu Y., Posey D.L., Cetron 
Source population(s): 
Migrants 
Eligible population: 
Migrants to the US 
 
Selected population: 
Immigrants and refugees 
who were initially screened 
for TB overseas between 
2007 and 2012 and arrived 
in the United States before 
1 May 2014 
Method of allocation: 
All immigrants after the 
implementation of the new 
strategy received the 
intervention 
 
Intervention(s) 
description: 
1. standard 
posteroanterior 
radiography of the chest 
for 
Primary outcomes: 
Annual number of TB 
cases  
 
Secondary outcomes: 
Follow-up numbers  
 
Method of analysis: 
Proportions  
Mean  
 
Primary results: 
- Annual number of CXR 
suspicion but sputum negative 
identified by the culture based 
algorithm: 
*1532 in 2007  
*14,292 in 2012 
- Annual number of cases 
diagnosed overseas by the 
culture-based algorithm: 
* 14 in 2007  
* 1058 in 2012 
Limitations identified by 
author: 
- This analysis did not 
control for the decline in 
new arrivals of non-
immigrant visitors 
(students etc) to the United 
States and the decrease of 
incidence of TB in their 
countries of origin. 
- Assumptions used for 
estimating the number of 
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M. S. et al., Effect of a 
Culture-Based Screening 
Algorithm on Tuberculosis 
Incidence in Immigrants and 
Refugees Bound for the 
United States: A Population-
Based Cross-sectional Study. 
Annals of Internal Medicine, 
2015. 162(6): p. 420-8. 
 
Aim of study: 
To evaluate the effect of the 
culture-based algorithm on 
preventing the importation 
of TB to the United States by 
immigrants and refugees 
from foreign countries. 
 
Study design: 
Population-based, cross-
sectional study 
 
Quality score: 
+ 
 
Applicability: 
+ 
 
Excluded population: 
NR 
 
Setting: 
Pre-migration screening at 
US migration stations 
 
Sample characteristics: 
Previous programme: 
- F:M = 54.5% - 45.5% 
- 50.7% 15-44 years old 
- Larges group= Mexicans 
- TB incindence rate home 
country: 20-99/100,00 = 
45% 
>100/110,000 = 44.3% 
 
New programme: 
- F:M = 54.8% - 45.2% 
- 51.2% 15-44 years old 
- Larges group= Mexicans 
- TB incindence rate home 
country: 20-99/100,00 = 
50.2% 
>100/110,000 = 47.1% 
 
- The highest TB 
prevalence: Vietnamese 
(890 cases/100,000) and 
Philippines 
(854 cases/100,000). 
 
- Between 2007 and 2012, 
refugees made up only 
14.9% of persons screened 
by the culture-based 
algorithm but accounted 
for 27.4% of TB cases 
diagnosed overseas among 
immigrants and refugees 
bound for the United 
States. 
persons aged 15 years or 
older 
2. chest radiographs 
suggestive of active TB or 
with symptoms of TB, 
sputum specimens were 
collected 2007 M. 
tuberculosis culture 
3. persons aged 2 to 14 
years in countries with a 
WHO-estimated incidence 
of 20 cases or greater per 
100 000 persons per year 
to have screening for latent 
M. tuberculosis infection 
4. complete overseas 
TB treatment (DOT) 
5. Persons with a class A 
TB waiver were mandated 
to report to health 
departments for follow-up 
evaluation after arrival. 
 
We analyzed a national 
data set from the CDC's 
Electronic Disease 
Notification 
(EDN) database to 
evaluate the effect of  
implementing the culture-
based algorithm in 
immigrants and refugees 
from 2007 to 2012 
 
Comparator/ control(s) 
description: 
annual number of reported 
TB cases among foreign-
born persons within 1 year 
after arrival from the U.S. 
National Tuberculosis 
Surveillance System 
between 2002 and 2012 
 
We compared the 
Modelling method and 
assumptions: 
The authors assumed that 
the number of immigrants 
screened overseas was 
equal to the number of 
immigrant arrivals during 
a specific  year, and the 
number of immigrant 
arrivals was uniformly 
distributed by month within 
a specific year. 
Time horizon: 
2007 and 2012 arriving in 
the US before 01.05.2014 
- Number of people screened by 
culture increased from 6.2% in 
2007 to 76.2% in 2012 
- The number of smear positive 
cases were not reported by the 
CDC before 2007 
 
- 1,561,460 persons screened by 
sputum culture strategy (2007-
2012): 
- 4032 active TB 
*751 smear-positive/ culture-
positive TB 
*606 smear-positive/culture-
negative TB 
*2195 smear-negative/culture-
positive TB 
*480 clinically diagnosed TB 
-Smear-negative/ culture-positive 
TB 
= 54.4% of cases diagnosed 
(2007-2012) 
 
Secondary results: 
- Of the 21,638 suspicious CXR 
but negative sputum smear 
identified (2002-2006) 11,686 
(54.0%) completed follow-up 
evaluation in the United States 
- Of the 60,423 suspicious CXR 
but with a negative sputum 
smear/ culture identified by the 
culture-based 
algorithm, 40,896 (67.7%) 
completed follow-up evaluation 
 
Follow-up evaluation active TB 
cases in: *410 (3.5%) screened 
by the smear-based algorithm 
 *731 (1.8%) screened by the 
culture-based algorithm (p < 
0.001) 
 
Before implementation (2002 to 
2006), the annual number of 
immigrants screened by the 
culture-based algorithm 
may be invalid. 
- Misclassification may 
have happened 
- In 2007, the CDC started 
requiring 
state and local health 
departments to enter 
follow-up evaluation data 
via its newly developed 
EDN 
database.- before that 
limited data collected 
 
Limitations identified by 
review team: 
- Not corrected for possible 
confounders 
- active TB cases 
diagnosed in home country 
not recorded before 2007. 
 
Evidence gaps and/or 
recommendations for 
future research: 
Cost-effectiveness study of 
the culture-based 
algorithm 
 
Source of funding: 
None 
 
Conflict of interests: 
No conflicts of interest 
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cumulative sum of the 
differences with the total 
number of smear-
negative/culture-positive 
TB cases diagnosed 
overseas among 
immigrants and refugees 
bound for the United States 
by the culture-based 
algorithm during 
implementation. 
 
Baseline comparisons: 
Annual number of reported 
TB cases among foreign-
born persons within 1 year 
after arrival before 
implementation (2002 to 
2006) as the baseline, we 
calculated the difference 
between the baseline and 
the annual number of 
reported TB cases among 
foreign-born persons 
within 1 year after arrival 
during implementation 
(2007 to 2012). 
Study sufficiently 
powered: 
Yes, large number 
reported cases among foreign-
born persons within 1 year after 
arrival in the United States was 
relatively constant (range, 1424 
to 1626 cases; mean, 1504 cases). 
During the implementation 
(2007 to 2012), the annual 
number of reported TB cases 
among foreign-born persons 
within 1 year after arrival 
decreased from 1511 to 940. 
 
During the same period, the 
annual number of smear-
negative/culture-positive TB 
cases diagnosed overseas among 
immigrants and refugees bound 
for the United States by the 
culture-based algorithm 
increased from 4 to 629 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
Israel 
 
Authors: 
Mor Z., Leventhal A., 
Weiler-Ravell D. et al. 
 
Year: 
Source population(s): 
Migrants 
 
Eligible population: 
Ethiopian migrants to 
Israel 
 
Selected population: 
Method of allocation: 
All non-pregnant 
immigrants older than 1 
year coming from Ethiopia 
get a CXR 2-3 weeks prior 
to air-travel 
 
Primary outcomes: 
The efficacy and is a 
statistically pure 
characteristic of CXR 
 
Secondary outcomes: 
The effectiveness of this 
instrument and may better 
Primary results: 
CXR as a screening tool for 
clinical detection of PTB:  
- Sensitivity: 80.1% (95% CI 
68.1– 89.9%) 
- Specificity: 99.2% (95% CI 
99.1–99.4%) 
- PPV: 31% (95% CI 23.4 –
Limitations identified by 
author: 
- Incomplete access to TST 
results and the missing 
clinical symptoms of the 
immigrants screened 
weaken the study 
-  CXRs were read by 
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2012 
 
Citation: 
Mor Z., Leventhal A., 
Weiler-Ravell D. et al. Chest 
Radiography Validity in 
Screening Pulmonary 
Tuberculosis 
in Immigrants From a High-
Burden Country.  Respir 
Care.2012;57(7): 1137–
1144 
 
Aim of study: 
To determine the validity of 
CXR screening in detecting 
radiological findings 
compatible with active 
PTB or with old healed 
tuberculosis (OHTB) 
 
Study design: 
Retrospective record review  
Cross-sectional study 
 
Quality score: 
+ 
 
Applicability: 
+ 
Jewish Ethiopian migrants 
to Israel 
 
Excluded population: 
Pregnant women 
Infants <1 y.o. 
Low quality CXR or 
missing CXR 
 
Setting: 
Pre-migration screening 
for Jewish Ethiopian 
migrants to Israel 
 
Sample characteristics: 
- 14,768 Jewish 
Ethiopian immigrants 
arrived in Israel 
- 13,379 
(90.6%) underwent CXR in 
Ethiopia.  
- 1,131 were pregnant 
women or infants <1 year. 
- PTB was suggested in 
150 (1.1%) of films 
- OHTB was 
suggested in 257 (1.9%) 
- 12,972 (97%) films were 
unremarkable or 
demonstrated other 
abnormalities unrelated to 
tuberculosis 
 
- Of all immigrants 
screened in Ethiopia, 57 
(0.4%) were diagnosed 
with active PTB, including 
the undocumented cases. 
Of those, 46 (81%) had a 
CXR suggestive of PTB, 
and 11 (19%) patients had 
an unremarkable CXR 
(clinical diagnosis/ 
questionnaire suggestive – 
smear/culture +ve). 
Intervention(s) 
description: 
Ethiopia: 
- CXR prior to immigration 
(all films are read by 
radiography department 
Carmel Hospital, Haifa, 
Israel) 
- Symptom questionnaire 
- Physical examination 
- one-step TST 
 
If previous Rx for TB / 
CXR abnormalities / 
questionnaire positive  3 
sputum samples (smear 
and culture) 
 
If sputum +ve treated in 
Ethiopia by DOTs, later 
resumed in Israel 
 
In Israel: 
- housed in absorption 
centre for >1 year 
- within 1 week: nurse 
comes to check HIV status 
and do 2nd TST (if 1st one 
<10 mm) 
 
If TB suspected – referral 
to TB clinic (for testing ± 
DOTS) 
 
All other pt’s with 
unremarkable CXR are 
followed by nurse for 1 
year 
 
Comparator/ control(s) 
description: 
Accuracy of 
CXR was determined by 
the diagnosis of active PTB 
using 2 end points as a 
reflect the “real life” 
clinical use of CXR, as 
some areas in developing 
countries may lack the 
capacity to perform 
culture. 
 
Method of analysis: 
Comparisons between 
groups were made using 
the chi-square or Fisher 
exact test for categorical 
variables and the Student t 
test for continuous 
attributes 
 
The accuracy attributes of 
CXR were expressed by 
sensitivity, specificity, 
positive and negative 
predictive values 
(PPV and NPV, 
respectively), and positive 
and negative diagnostic 
likelihood ratios. 
 
Modelling method and 
assumptions: 
Accuracy of CXR in 
detecting PTB in mass 
screening of individuals 
from high-burden 
countries justifies the 
process 
 
Time horizon: 
July 2001- Dec 2005 
38.7%) 
- NPV: 99.9% 
(95% CI 99.8–99.95%) (Table 2).  
 
CXR as a screening tool for 
microbial detection of PTB: 
- Sensitivity: 86.1% (95% CI 
72.1–94.7%) 
- Specificity: 99.1% 
(95% CI 99.0 -99.3%) 
- PPV: 24.7% (95% CI 18.0–
32.4%) 
- NPV: 99.9% (95% CI 99.92–
99.99%) 
 
The positive diagnostic likelihood 
ratio for a CXR suggestive of 
PTB was 100.1 (the probability of 
an immigrant whose CXR is 
suggestive of PTB to be 
diagnosed with active PTB is 100 
times greater than those who 
CXR is unremarkable). 
 
The negative diagnostic 
likelihood ratio was 0.2 
(unremarkable CXR is 5 times 
more common in healthy 
immigrants than in those who 
developed active PTB). 
 
The diagnostic yield of OHTB-
CXR using active PTB diagnosis 
during the first year following 
immigration as the end point was 
calculated: 
Sensitivity was 17.2% (95% CI 
10.0–26.9%), specificity was 
98.2% (95% CI 97.9–98.4%), and 
PPV was 5.8% (95% CI 3.31–
9.4%).  
The positive diagnostic like- 
lihood ratio for a CXR suggestive 
of OHTB was 9.4.  
 
several radiologists, so the 
results are subject to 
interobserver differences. 
In order to minimize over- 
and under-reporting, all 
the readings were 
performed in the same 
radiology ward, supervised 
by a single senior 
physician 
- PPV is dependent on the 
prevalence of the disease 
in the population studied. 
 
Limitations identified by 
review team: 
- Patients with a normal 
CXR had no sputum 
culture comparison  
- Costs-analysis / argument 
is not completely 
convincing: what are the 
costs of treatment in 
Ethiopia? And, authors say 
“Treatment is later 
continued in Israel” – after 
how long are TB+ 
migrants allowed to enter 
the country – and what will 
then be the in-country cost 
for treatments? 
 
Evidence gaps and/or 
recommendations for 
future research: 
Cost-effectiveness analysis  
 
Source of funding: 
This study was partially 
sponsored by the League 
Against Tuberculosis 
and Lung Diseases, 
Rehovot, Israel, and by the 
National Institute for 
Health Policy and Health 
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- Five PTB patients had 
negative cultures and 
unremarkable CXR 
- 3 PTB pt’s were HIV +ve  
 
gold standard for PTB: 
microbial and clinical. 
 
Baseline comparisons: 
- CXR PTB vs PTB 
clinical suspicion- CXR 
PTB vs PTB Microbial 
Confirmation  
- CXR OHTB vs PTB 
Microbial confirmation 
within first year 
 
Study sufficiently 
powered: 
Yes.  
Secondary results: 
PTB pre-test probability of this 
cohort was 0.43% 
(57/13,379), pre-test odds were 
0.75 and the post-test odds for 
CXR suggestive of PTB were 
75.5. These calculations 
represent a more accurate 
estimation of the yield of CXR in 
a “real life” setting, meaning that 
an Ethiopian immigrant whose 
CXR demonstrates changes 
suggestive of PTB is >75 times 
more likely to be diagnosed with 
PTB than an immigrant whose 
CXR is unremarkable. 
 
- 291 films are required to detect 
a single case of active PTB upon 
immigration. 
- The cost of performing a single 
CXR in Ethiopia, including its 
reading in Israel, is $20 
(including direct cost of CXR in 
Addis Ababa, reading of CXR in 
Israel, and indirect costs in 
Ethiopia, such as maintenance of 
the health station and salaries). 
Thus, the total amount required 
to detect one PTB case among 
immigrants is $5,820. 
Treating an active PTB patient in 
Israel, which is $7,619 (based on 
the Israeli Ministry of Health 
tariffs in Israel, January 2005).  
Services Research, Tel-
Hashomer, Israel.  
 
Conflict of interests: 
None 
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Country: 
Israel 
 
Authors: 
Mor Z., Weinstein O., 
Tischler-Aurkin D. et al. 
 
Year: 
2015 
 
Citation: 
Mor Z., Weinstein O., 
Tischler-Aurkin D. et al. The 
Yield of Tuberculosis 
Screening of Undocumented 
Migrants from the Horn of 
Africa based on 
Chest Radiography. IMAJ, 
2015(17):11-13 
 
Aim of study: 
To evaluate the validity of 
CXR and assess its related 
costs in detecting TB among 
undocumented migrants in 
Israel from the Horn of 
Africa. 
 
Study design: 
cross-sectional study 
 
Quality score: 
- 
 
Applicability: 
- 
Source population(s): 
Migrants 
 
Eligible population: 
Illegal immigrants 
 
Selected population: 
Detained illegal 
immigrants in Israel from 
the Horn of Africa (Sudan, 
Ethiopia & Eritrea) 
 
Excluded population: 
Everyone who had a CXR 
done at another institution 
 
Setting: 
TB screening for illegal 
immigrants from the Horn 
of Africa in an detention 
centre in Israel.  
 
Sample characteristics: 
- 5335 migrants who 
crossed the southern 
Israeli border illegally and 
were detained during 2009 
- 1087 (20.4%) underwent 
CXR at a single institution. 
 
- 641 (59.0%) were 
Eritreans 
- 280 (25.7%) 
Sudanese  
- 166 (15.3%) Ethiopians. 
- male:female= 8.1:1  
- average age = 34.8 ± 
17.2 years. 
Method of allocation: 
Random selection by the 
Israeli Prison Services  
 
Intervention(s) 
description: 
1. Detention centre 
2. Screened for TB by 
interview and CXR 
3. If positive referred to TB 
clinic for checkup & 
sputum 
4. If positive DOTS 
 
Comparator/ control(s) 
description: 
CXR compared with final 
TB diagnosis 
 
Baseline comparisons: 
CXR vs TB diagnosis 
(culture +ve or full course 
anti-TB therapy) 
 
Study sufficiently 
powered: 
Large sample size but 
small group of TB 
diagnosis 
Primary outcomes: 
Point prevalence 
 
Secondary outcomes: 
Commutative incidence: 
3-year follow up, who 
developed TB 
 
Method of analysis: 
- Comparisons between 
categorical and continuous 
variables were performed 
by the chi-square and 
Student’s t-test, 
respectively 
- Validity of 
the CXRs was expressed by 
sensitivity, specificity and 
positive predictive values 
(PPV), while active TB 
detection was considered 
the end-point. 
- If positive in 3-year 
follow-up period: 
reevaluation CXR + 
medical records  
 
Modelling method and 
assumptions 
NR 
 
Time horizon: 
2009 
Primary results: 
- 62/1087 (5.7%) of the CXRs 
demonstrated  suggestive of TB 
- 11/62 were finally diagnosed as 
having TB at TB clinic (17.7% of 
all suspicious CXRs) 
 
- sensitivity 100% 
- specificity 96.1% 
- PPV 17.7%  
 
- 10/11 (90.9%) pulmonary TB 
- 1/11 (9.1%) extra-pulmonary 
TB 
- Smear +ve results in 3/11 
(27.3%)  
- Culture positive in 8/11 (72.7%)  
- All 8 cultures were sensitive for 
first-line drugs, while 3/8 (37.5%) 
were streptomycin resistant. 
TB point-prevalence on arrival 
was 1000 cases per 100,000 
migrants (1.0%)  
 
The interview, which failed to 
identify most of the migrants who 
were diagnosed with TB (mainly 
negative answers), is considered 
a low 
sensitivity instrument due to 
linguistic barriers and possible 
reporting bias, since incarcerated 
migrants may respond in a way 
that they believe would hasten 
their discharge. 
 
The detection of 11 TB patients 
required 1078 CXRs and 62 TB 
clinic evaluations, at direct costs 
of 98 and 1434 shekels 
(NIS) (US$ 25 and 367) each, 
respectively, accumulating in NIS 
17,970 ($ 4585) to detect one TB 
patient. Conversely, the cost for 
treating a single TB patient in 
Limitations identified by 
author: 
- only the questionnaires 
of confirmed TB cases 
were traced; the 
questionnaires 
from the entire cohort 
could not be found. 
- only ± 70%  of the CXRs 
of the migrants diagnosed 
in the community could be 
located because of 
technical factors 
-  the small number of TB 
patients who were 
diagnosed with TB limits 
comparisons. 
- CXR is not indicated for 
detecting cases of extra-
pulmonary TB, although it 
is less prioritized in terms 
of public health concerns 
 
Limitations identified by 
review team: 
- Only CXR’s done at 1 
institution analysed – risk 
of selection bias 
- No information on lost-
to-follow up (3 years!) 
- No procedures described 
for random selection – 
potential selection bias 
- No information on the 
follow-up on X-rayed 
participants (although this 
was not a study objective, 
could have provided 
interesting information) 
- none of the included 
migrants developed active 
TB during the detention 
period – but detention time 
is too short – sensitivity 
calculated too high 
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Israel is ~ NIS 28,700 ($ 7335). 
 
Secondary results: 
88 pt’s developed TB but not in 
scope of this review 
- No real cost-analysis 
given, the costs of the 
screening was presented 
but no comparison was 
made if this is cost 
effective.  
 
Evidence gaps and/or 
recommendations for 
future research: 
Real cost-effectiveness 
study 
 
Source of funding: 
This study was partially 
funded by the Israeli Lung 
and Tuberculosis 
Association 
 
Conflict of interests: 
NR 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
US/Vietnam 
 
Authors: 
Painter J.A. Graviss E.A. 
Hoa Hai H. et al. 
 
Year: 
2013 
 
Citation: 
Painter JA, Graviss EA, Hai 
HH. et al. (2013) 
Tuberculosis Screening by 
Tuberculosis Skin Test or 
QuantiFERON®-TB Gold 
In-Tube Assay among an 
Source population(s): 
Migrants 
 
Eligible population: 
Migrants to the US from 
Vietnam 
 
Selected population: 
Vietnamese visa applicants 
during the standard 
immigrant medical 
examination at the Cho 
Ray Hospital Medical Visa 
Unit, age >14 years 
 
Excluded population: 
NR 
Method of allocation: 
Every applicant with a 
chest radiograph 
consistent with 
tuberculosis was 
approached for enrollment. 
Each week, the first 
available participants with 
a normal chest radiograph 
were enrolled to maintain 
the 2:1 ratio 
 
Intervention(s) 
description: 
QFT was performed on the 
day of enrollment, followed 
by TST, TST reading in 48 
Primary outcomes: 
To measure the sensitivity 
of TST and QFT in 
detecting culture-
confirmed pulmonary 
tuberculosis 
 
Secondary outcomes: 
To estimate the overall and 
age-specific prevalence of 
LTBI for using TST and 
QFT in the same adult 
immigrant population (not 
for our study) 
 
Method of analysis: 
To measure the sensitivity 
Primary results: 
- 1,475 participants >14 y.o. 
enrolled 
- 479 had Normal-CXR  
- 996 had CXR consistent with TB 
- 100 applicants declined  
- 5 did not complete examination 
 
- 132 (13.3%) were culture-
confirmed for tuberculosis (TB)  
- 864 were not culture confirmed 
(TBCXR) 
 
- Culture-confirmed cases were 
identified on the first sputum 
sample for 95 (72.0%) 
- 27 (20.4%) additional cases 
Limitations identified by 
author: 
1. no acid-fast bacilli 
sputum smears or cultures 
were obtained for 
applicants with chest 
radiographs not suggestive 
of tuberculosis – unlikely 
but may be TB +ve 
2. the tuberculosis 
infection status cannot be 
determined with 
certainty because there is 
no gold standard for LTBI 
detection  unable to 
calculate specificity 
3. BCG immunization Hx 
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Immigrant Population with a 
High Prevalence of 
Tuberculosis and BCG 
Vaccination. PLoS ONE 
2013. 8(12): e82727 
 
Aim of study: 
To measure the sensitivity of 
TST and QFT in detecting 
culture-confirmed 
pulmonary tuberculosis 
 
Study design: 
Comparison study 
 
Quality score: 
+ 
 
Applicability: 
+ 
 
Setting: 
Cho Ray Hospital Medical 
Visa Unit 
 
Sample characteristics: 
- 20,100 visa applicants 15 
years of age and older 
- mean age was 37.3 years 
- 17,802 (88.6%) normal-
CXR 
- 2,087 (10.4%) TB-CXR 
- 211 (1,040 per 
100,000 population) 
culture-confirmed 
pulmonary TB 
 
 
 
 
to 72 hours. Followed by 
sputum cultures 
 
Comparator/ control(s) 
description: 
1) having a chest 
radiograph not consistent 
with TB (Normal-CXR)  
2) having a chest 
radiograph consistent with 
TB but not culture 
confirmed (TB-CXR) 
3) having culture-
confirmed pulmonary 
tuberculosis (TB) when 
M.tuberculosis was 
isolated from any of the 
three sputum samples. 
 
Baseline comparisons: 
Sensitivity of TST versus 
QFT-G for culture 
confirmed pulmonary TB 
 
Study sufficiently 
powered: 
Did not meet the 150 
culture confirmed cases 
that was determined before 
the start of the study 
(included 132 culture 
confirmed cases) 
for culture-confirmed 
pulmonary tuberculosis, 
we calculated the percent 
positive results only among 
those having culture-
confirmed pulmonary 
tuberculosis (TB). 
 
Estimated the annual 
percent change for having 
a chest radiograph 
consistent with 
tuberculosis, culture 
confirmed tuberculosis, 
and a positive TST or QFT. 
 
Modelling method and 
assumptions: 
NR 
 
Time horizon: 
From December 2008 
through January 2010 
were identified on the second 
sputum sample 
- 10 (7.6%) on the third sputum 
sample 
 
The sensitivity for detecting 
culture-confirmed tuberculosis 
was: 
- 86.4% (95% CI = 79.3%-
91.7%) for QFT 
- 89.4% (82.8%-94.1%) for TST-5 
- 81.1% (73.3%-87.5%) for TST-
10 
- 52.3% (43.4%-61.0%) for TST-
15 
 
These results were significantly 
different for QFT versus TST-15 
(Pearson's chi-squared 
probability [p]=<0.001) but not 
for QFT versus 
TST-5 (p=1) or TST-10 (p=0.12) 
 
Neither the TST at the most 
sensitive (5-mm) cutoff or QFT 
detected all the culture-positive 
pulmonary tuberculosis cases 
detected by the rigorous 
radiologic and microbiologic 
screening, 
 
Secondary results: 
The annual percentage increase 
per year of age was 5.5% [95% 
confidence interval = 5.2%—
5.8%] for a CXR consistent with 
TB and 2.9% [2.0%—3.8%] for 
culture-confirmed TB 
 
Conclusion: 
In addition to similar sensitivity 
in detection of tuberculosis, two 
principal findings support the use 
of QFT over TST for two-stage 
TB screening in this BCG-
not obtained – assumed 
everyone was immunized 
4. Only 1 HIV positive 
patient 
 
Limitations identified by 
review team: 
- Only sensitivity 
measured, not specificity 
- No cost-effectiveness 
analysis 
- Harms/side effects of 
different tests not assessed 
 
Evidence gaps and/or 
recommendations for 
future research: 
- Study the specificity as 
well 
- Cost-effectiveness 
analysis 
- Assess harms 
 
 
Source of funding: 
CDC 
- QFT-G kits were 
provided by the 
Foundation for Innovative 
New Diagnostics 
 
Conflict of interests: 
NR 
42 
 
vaccinated population. 
- positive test result for LTBI 
would lead to radiography of only 
37% of the entire population with 
a positive QFT compared with 
72% of those with a positive TST-
5 with no difference in case 
detection 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
US 
 
Authors: 
Posey  D.L., Naughton  
M.P., Willacy  E.A. et al. 
 
Year: 
2014 
 
Citation: 
Posey  D.L., Naughton  
M.P., Willacy  E.A. et al. 
Implementation of New TB 
Screening Requirements for 
U.S.-Bound 
Immigrants and Refugees – 
2007-2014. Morbidity and 
Mortality Weekly Report 
2014(63):11;234-236  
 
Aim of study: 
Summarizes the worldwide 
implementation of the new 
screening requirements 
(2007) – CDOT TB TI 
 
Study design: 
Quantitative report 
 
Source population(s): 
Migrants 
 
Eligible population: 
US bound migrants 
 
Selected population: 
US bound migrants 
applying for a visa and 
attend TB screening in 
their home country 
 
Excluded population: 
Not reported 
 
Setting: 
Not reported 
 
Sample characteristics: 
Not reported 
Method of allocation: 
pre- and post-intervention 
 
Intervention(s) 
description: 
Overseas identification and 
treatment of TB in US 
bound immigrants by: 
- medical examination 
- CXR 
- sputum smears 
 
CDOT TB TI: 
CDC added sputum 
cultures, drug 
susceptibility testing and 
DOTS in 2007 
 
In 2009 TST & IGRA for 
children 2-14 y.o.  
 
Comparator/ control(s) 
description: 
no comparison done 
 
Baseline comparisons: 
Not done 
 
 
Primary outcomes: 
Increased yield by new 
screening method 
 
Secondary outcomes: 
- Prevalence TB cases 
- Cost effectiveness 
 
Method of analysis: 
prevalence of smear-
negative culture positive 
TB cases 
 
Modelling method and 
assumptions: 
authors assumed that 
smear-negative, culture 
positive cases without the 
intervention would have 
been missed 
Time horizon: 
2007-2014 
Primary results: 
In 2012: 
1,100 cases of TB were diagnosed 
- Approximately 60% of all cases 
were smear negative, 
but culture-positive Because the 
previous system did not require 
cultures, the smear-negative but 
culture-positive 
cases represent a gain in TB 
diagnoses with the new CDOT TB 
TI requirements.  
- 14 cases were MDR-TB 
 
Secondary results: 
In addition to increasing the yield 
of diagnoses overseas, 
implementation of CDOT TB TI 
was temporally associated with a 
decline in TB cases among 
foreign-born persons in the 
United States  since 2007 
 
During the period in which the 
1991 TB TI was in use, 7% of 
immigrants and refugees who had 
abnormal CXR suggestive of TB, 
but negative sputum smears, were 
diagnosed with TB disease after 
their arrival in the United States. 
Limitations identified by 
author: 
None 
 
Limitations identified by 
review team: 
Is a report, not true 
comparison study 
 
Evidence gaps and/or 
recommendations for 
future research: 
- Cost-effectiveness study 
- True comparison  study  
 
Source of funding: 
NR 
Conflict of interests: 
NR 
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Quality score: 
- 
 
Applicability: 
- 
Study sufficiently 
powered?: 
NA 
Under CDOT TB TI, early data 
suggest that percentage has 
declined to 1%–2% 
 
Although formal economic 
analyses have not been 
completed, 
the gains in overseas diagnosis 
and the decrease in cases suggest 
that successful implementation of 
this screening program 
could result in crude savings in 
excess of $15 million yearly. 
 
Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
Estonia 
 
Authors: 
Ruutel K. Loit H-M. Sepp T. 
et al.  
 
Year: 
2011 
 
Citation: 
Ruutel K. Loit H-M. Sepp T. 
et al. Enhanced tuberculosis 
case detection among 
substitution treatment 
patients: a randomized 
controlled trial. BMC 
Research Notes 2011,4:192 
 
Aim of study: 
To evaluate case 
management interventions 
aimed at increasing 
tuberculosis screening & 
Source population(s): 
IVDU  
 
Eligible population: 
IVDU at community-based 
methadone substitution 
treatment center  
 
Selected population: 
IVDU at community-based 
methadone substitution 
treatment center in Johvi. 
 
- participate in substitution 
treatment program 
- >18 y.o. 
- read/write in 
Estonian/Russian 
- provide informed consent 
Excluded population: 
No return for TST reading 
 
Setting: 
Method of allocation: 
Random allocation by 
nurse to passive (self) or 
active (nurse led) referral 
 
Intervention(s) 
description: 
Active referral (referral 
made and chased by study 
staff) to TB centre for TB 
screening 
 
At substitution center: - 
Mantoux (read 2-3/7 later; 
>5 mm = +) 
- Self administrated 
questionnaire 
- HIV + IGRA test 
(counselling) 
 
Random allocation to 
passive (self)/active 
(nurse)referral 
- F/U 2/12 after enrolment 
Primary outcomes: 
The influence of active 
referral on TB clinic 
attendance  
 
Association between 
participant characteristics 
and attendance to TB 
services  
 
Secondary outcomes: 
Cost assessment 
 
Method of analysis: 
Wilcoxon ranksum test/ 
Fisher exact test followed 
by univariate and 
multivariable log 
regression 
 
Modelling method and 
assumptions: 
The intervention will 
increase TB screening and 
Primary results: 
43.8% (49/112) attended TB 
clinic 
* 17 control group (30.4%) 
* 32 intervention group (57.1%) 
* no TB diagnosed 
 
Appointment organised and 
chased by nurse had 3.9x higher 
rate of attendance to TB service 
than making an appointment 
themselves (95% CI 1.4-10.4, 
p=0.007) 
 
TB clinic was not associated with 
any of the variables (age, 
education, work, prison, years of 
IVDU, Mantoux/HIV result, sex). 
Only with type of referral! 
 
Secondary results: 
Active case management costs an 
additional 18 euros per patient 
(food voucher, extra time nursing 
staff, transport)  
Limitations identified by 
author: 
- small sample size 
- one centre 
- methadone using group 
= not active IVDU, so 
results can’t be 
generalised to whole IVDU 
population 
- modest responds rate at 
methadone centre 
 
Limitations identified by 
review team: 
- IVDU had to travel 16 km 
to other hospital, in the 
active referral group 
transport was organised 
not for the passive referral 
= risk for bias 
- All TB negative cases 
?good representation of 
the population and unable 
to calculate cost made to 
detect 1 active TB case 
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treatment entry among 
IVDU  
 
Study design: 
Pilot -  RCT 
 
Quality score: 
+ 
 
Applicability: 
+ 
community-based 
methadone substitution 
treatment center in Johvi. 
 
Sample characteristics: 
189 invited – 112 
responded (59%) 
 
56 (50%) intervention, 56 
(50%) control group 
 
 
- Food voucher given for 
TST reading 
 
TB centre: 
- screened for active TB 
- doctors filled out 
questionnaire + final 
diagnosis 
 
Comparator/ control(s) 
description: 
Passive referral – IVDU 
has to make the referral 
appointment himself 
 
Baseline comparisons: 
TB screening attendance  
 
Study sufficiently 
powered?: 
P=0.007 
treatment entry among 
IVDU 
 
Time horizon: 
16-18 October 2007 
 
Conclusion: 
TB screening services can be 
increased with more active 
referral, help in transportation 
and incentives 
 
 
Evidence gaps and/or 
recommendations for 
future research: 
- TB screening centre 
closer by or screening 
closer to ‘home’ 
- - Longer enrolment 
period 
/larger sample size too be 
able to calculate costs 
made to detect 1 active TB 
case 
- broader spectrum of 
IVDU not just at 
methadone clinic 
 
Source of funding: 
National institute for 
health development 
Estonia, National 
HIV/AIDS strategy 2006-
2015, National 
Tuberculosis Control 
Program 2003-2007, 
Estonian Ministry of 
Education and research, 
New York State 
International Training and 
Research Program, 
National Institute of 
Health/Fogarty 
International Center and 
the National Institute of 
Drug Abuse 
 
Conflict of interest: 
None 
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Study details Population and setting Method of allocation to 
intervention/ control 
Outcomes and methods 
of analysis 
Results Note by review team 
Country: 
Switzerland 
 
Authors: 
Schneeberger Geisler S., 
Helbling P., Zellweger J.P., 
Altpeter E.S. 
 
Year: 
2010 
 
Citation: 
Schneeberger Geisler S., 
Helbling P., Zellweger J.P., 
Altpeter E.S. Screening for 
tuberculosis in asylum 
seekers: comparison of chest 
radiography with an 
interview-based system. Int J 
Tuberc Lung Dis 
14(11):1388-1394 
 
Aim of study: 
To compare the detection of 
pulmonary TB by TB 
screening by a symptom-
based questionnaire (2007-
2008) versus TB screening 
by chest radiography (2004-
2005)  
 
Study design: 
Cross-sectional 
retrospective comparison of 
two 2-year periods 
 
Quality score: 
+ 
 
Source population(s): 
Migrants 
 
Eligible population: 
Asylum seekers 
 
Selected population: 
Asylum seekers in 
Switzerland form high 
endemic countries 
 
Excluded population: 
- Double entries  
- Repeated screening 
examinations 
 
Setting: 
Mandatory initial 
screening of asylum 
seekers 
for tuberculosis (TB) in 
Switzerland, 2004–2005 
and 
2007–2008. 
 
Sample characteristics: 
- A total of 25,856 persons 
applied for asylum in 
Switzerland during the 
period from 2004 to 2005, 
and 
27,450 in the period from 
2007 to 2008 
- Men were more 
frequently affected than 
women. 
- Asylum seekers between 
the ages of 15 and 54 years 
had a higher prevalence of 
Method of allocation: 
All cases 2004-2005 had 
screening with CXR all 
cases 2007-2008 were 
screened with 
questionnaire. 
 
The national register of all 
TB cases notified in 
Switzerland  was merged 
with the central database 
of TB screening 
procedures of asylum 
seekers to identify cases 
appearing in both 
databases. 
 
Intervention(s) 
description: 
An expert system for a 
symptom-based interview 
was developed to replace 
routine radiography.  
 
The score is based on: 
- the estimated prevalence 
of TB in the country of 
origin (0 to 10 points) 
- symptoms elicited in the 
interview (up to 11 points) 
- the personal and family 
TB history (up to 2 points) 
- the overall impression 
gained by the interviewing 
nurse (0 or 3 points). 
 
Above a defined threshold 
of the score (10 points) or  
at the discretion of the 
Primary outcomes: 
The overall yield was the 
number of culture 
confirmed pulmonary TB 
cases that had been started 
on anti-tuberculosis 
combination treatment 
within 
90 days after screening in 
the two periods 
 
Secondary outcomes: 
Coverage and the initial 
results of the screening 
tool 
measured as sensitivity, 
specificity and, as a 
summary  measure for both 
sensitivity and specificity, 
the likelihood  ratios with 
95% confidence intervals 
(CIs): 
Sensitivity/(1 − specificity) 
for the positive and specifi 
city/(1 −sensitivity)/ for the 
negative ratio 
 
Method of analysis: 
- Sens/spec/ 95% CI’s/ pos. 
& neg. likelihood ratio 
- Treatment delay 
 
Modelling method and 
assumptions: 
The delay 
from screening to start of 
treatment was estimated 
using Kaplan-Meier 
survival analysis. 
Primary results: 
- 2004-2005:  
21,987 (coverage 84%)  
- 2007-2008:  
23,722 (coverage 85%) 
 
- Radiography led to more 
diagnoses of pulmonary TB that 
remained unconfirmed by culture 
 
- 2004–2005: all 31 cases of PTB 
had an abnormal CXR @ 
screening 
- 2007–2008: only 16/29 cases 
(55%) were identified as TB 
suspects at screening.  The 13 
cases not detected by screening 
had scores below the threshold 
for which further investigations 
for TB were required. These 
cases also needed medical 
attention in the weeks following 
the screening procedure when 
they developed symptoms. 
 
- CXR screening resulted in a 
faster identification of PTB. The 
median delay from screening to 
treatment was 6 days in 2004–
2005 (range 0–79) and 25 days 
(range 0–85) in 2007–2008 
The median delay in the subgroup 
not identified by screening in 
2007–2008 was 40 days (range 
16–85). 
 
Secondary results: 
2004-2005: 
- sensitivity 100%  
Limitations identified by 
author: 
- The effect of the new 
system cannot be 
determined accurately, as 
the two systems were not 
run in parallel. 
(geographic origins 
changed, but both groups 
could stay in the country 
for 90 days – 90 days was 
chosen as the effect of 
screening diminishes 
rapidly over time, after 90 
days it might be 
reactivation of LTBI 
instead of earlier active 
TB) 
- Communication 
problems, including 
differential conceptual 
representation 
of illness, and the belief 
that being ill might 
negatively affect the 
chances of being granted 
asylum, may play a role. 
Interestingly, most such 
cases originated from the 
Horn of Africa 
 
Limitations identified by 
review team: 
- Small number of people 
starting Rx in 90 days 
- Did not evaluated culture 
negative cases started on 
TB treatment 
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Applicability: 
++ 
pulmonary TB than other 
age groups. 
nurse, the screened asylum 
seeker is referred 
to a clinician for further 
evaluation, which always 
includes a chest 
radiograph. Abnormal 
radiographs require 
microbiological 
examinations. 
 
Comparator/ control(s) 
description: 
Compare with systematic 
radiographic 
screening (system in 2004-
2005). 
 
Baseline comparisons: 
Compare the 
detection of pulmonary TB 
within 90 days 
(microbiological 
confirmation + start of TB 
treatment) 
 
Study sufficiently 
powered: 
Yes, but small number of 
TB patients identified 
 
- two-by-two tables were 
evaluated  
 
Time horizon: 
2004–2005 and 
2007–2008 
 
- specificity 89.6%  
- positive likelihood ratio was 
9.99 (95%CI 9.99–10.0)  
- negative likelihood ratio was 
0.00 (95%CI 0–∞ ) 
 
2007–2008: 
- sensitivity 55.2%,  
- specificity 96.0% 
- positive likelihood 
ratios 13.7 (95%CI 12.37–15.15)  
- negative likelihood ratios 0.5 
(95%CI 0.40–0.54) 
 
The three highest positive 
likelihood ratios were for 
subjects presenting with: 
- illness as judged by the nursing 
staff (21.3, 95%CI 3.22–141) 
- mentioning previous 
anti-tuberculosis treatment (17.9, 
95%CI 7.38– 
43.50)  
- stating cough (3.4, 95%CI 2.83– 
4.09) 
- 12% of all 
screened asylum seekers in 2004–
2005 vs. 4% in 2007–2008, with 
corresponding yields of 
respectively 1.4% and 1.7% 
needed further investigations 
Evidence gaps and/or 
recommendations for 
future research: 
- Compare the 2 systems 
over the same time period 
and the same populations 
- Cost-effectiveness study 
 
Source of funding: 
NR 
(Study was performed by 
the Federal Office of 
Public Health) 
 
Conflict of interests: 
NR 
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Country: 
UK 
 
Authors: 
Story A., Aldridge R.W., 
Abubakar I. et al.  
 
Year: 
2012 
 
Citation: 
Story A., Aldridge R.W., 
Abubakar I. et al. Active 
case finding for pulmonary 
tuberculosis using mobile 
digital chest radiography: 
an observational study. Int J 
Tuberc Lung Dis. 2012. 
16(11):1461–1467 
 
Aim of study: 
1. To calculate the sensitivity 
and specificity 
of mobile digital CXR for 
identifying pulmonary TB 
among high risk groups in 
an urban setting (London) 
2. to determine whether 
cases of active pulmonary 
TB identified by MXU were 
less likely to be sputum 
smear positive on diagnosis 
than passively identified 
cases from the same 
populations 
 
Study design: 
Observational study 
 
Quality score: 
+ 
 
Applicability: 
++ 
Source population(s): 
Homeless, drug users, 
prisoners and asylum 
seekers 
 
Eligible population: 
Homeless, drug users, 
prisoners and asylum 
seekers in London, the UK 
 
Selected population: 
Homeless, drug users, 
prisoners and asylum 
seekers in London, the UK 
using services for their 
population group 
 
Excluded population: 
- Aged under 16 years at 
the time of screening 
- If not classified in the 
homeless, 
asylum, drug user or 
prison risk groups 
- Non-pulmonary cases 
notified within 90 days, 
including those with extra-
pulmonary but 
intrathoracic disease 
 
Setting: 
TB screening in hard-to-
reach groups in London 
 
Sample characteristics: 
47 510 CXRs were 
performed among 
individuals: 
- 19,801 homeless (41.7%) 
- 15,580 prisoners (32.8%) 
- 4,220 asylum seekers 
(8.9%) 
- 4,173 drug users (8.8%) 
- 3736 others (7.9%) 
 
Method of allocation: 
All homeless, drug users, 
prisoners and asylum 
seekers present at the 
venue at the time of 
screening 
 
Intervention(s) 
description: 
Mobile CXR unit screening 
2x a year at different 
venues 
- CXR evaluated on the 
spot by 2 radiographers 
*CXR positive = suspected 
TB 
*CXR negative = normal, 
old TB, abnormal CXR 
referred or not referred for 
further investigations 
- Everyone with a positive 
CXR was referred for 
further investigation 
 
Comparator/ control(s) 
description: 
culture-confirmed cases of 
PTB  notified to the ETS 
(Enhanced Tuberculosis 
Surveillance) within 90 
days of screening 
 
Baseline comparisons: 
TB diagnosis 
Primary outcomes: 
sensitivity and specificity 
of mobile digital CXR 
screening 
 
Secondary outcomes: 
Smear positive disease as 
specified by the Health 
Protection Agency (HPA) 
Actively identified cases 
(screening) were compared 
with passively identified 
cases (self presentation) 
 
odds ratios of sputum 
smear positivity 
 
Method of analysis: 
Sensitivity, specificity, 
NPV, PPV 
Logistic regression 
Univariate and 
multivariate analysis 
Modelling method and 
assumptions: 
Logistic regression 
adjusting for confounders 
(age, sex a priori), 
potential confounding 
variables identified at 
univariate analysis were 
added  
 
Time horizon: 
1 April 2005 to 31 March 
2010 
Primary results: 
- 38 717 deduplicated CXRs at 
MXU 
- 414 suspected TB cases at CXR 
- 33 culture confirmed within 90 
days  27 CXR +ve (so 6 CXR -
ve) 
- Sensitivity: 81.8% 
(95%CI 64.5–93.0) 
- Specificity: 99.2% (95%CI 
99.1–99.3) 
- PPV: 6.5% (27/414) 
NPV: 100% (47,090/47,096) 
 
Secondary results: 
- The odds of smear-positive 
disease was reduced in 
individuals seen by the MXU in 
the past 90 days (OR 0.37, 
95%CI 0.15–0.90, p =  0.03). 
 
- After adjusting for age and sex, 
there was evidence that the odds 
of smear positive disease were 
lower in MXU-identified cases of 
pulmonary disease than in 
passively identified cases from 
the same population (OR 0.34, 
95%CI 0.14–0.85, likelihood 
ratio test p = 0.022) 
 
Conclusion:  
Digital CXR achieves a high level 
of sensitivity and specificity in an 
operational setting; targeted 
Mobile radiographic screening 
can reduce the risk of onward 
transmission by identifying cases 
before they become infectious 
 
 
Limitations identified by 
author: 
- risk factors such as 
homelessness, drug use 
and incarceration were 
assigned depending on 
where screening occurred, 
therefore cannot account 
for the heterogeneity of 
these populations. For 
example, a high proportion 
of persons classified as 
homeless may also have 
concurrent drug use or a 
history of incarceration, 
and vice versa. 
- The linkage of individuals 
screened by the MXU to 
TB cases within the 
national surveillance 
system should not be 
differentially biased, but is 
likely to underestimate 
the total number of cases. 
- Analysis was based on 
existing data, collection of 
additional confounding 
variables was not 
impossible. 
- HIV status was not known 
 
Limitations identified by 
review team: 
- What % was sputum 
culture negative but had a 
suspected CXR? 
 - And what % did not 
show up for sputum test? 
The gold standard is now 
PTB notification to ETS 
- Selection bias 
 
Evidence gaps and/or 
recommendations for 
future research: 
48 
 
 
Study sufficiently 
powered?: 
Power calculation: 
estimated that 150 culture 
confirmed cases would 
show difference in % of 
smear positive disease of 
25%, with a power of 84% 
and a difference of 30% 
with 99% power and 0.05 
level of significance 
between active and passive 
case finding 
 
Study only found 33 culture 
confirmed cases 
Compare CXR with sputum 
culture, so at the day of 
screening, everyone with a 
positive CXR should have a 
sputum sample done as 
well 
 
Source of funding: 
National Institute 
for Health Research 
 
Conflict of interests: 
None 
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Supplementary Material IV: Evidence statements   
 
Grading of evidence 
 
No evidence – no evidence or clear conclusions from any studies; 
Weak evidence – no clear or strong evidence/conclusions from high quality studies and only tentative 
evidence/conclusions from moderate quality studies or clear evidence/conclusions from low quality studies; 
Moderate evidence – tentative evidence/conclusions from multiple high quality studies, or clear 
evidence/conclusions from one high quality study or multiple medium quality studies, with minimal 
inconsistencies across all studies;  
Strong evidence – clear conclusions from multiple high quality studies. 
 
 
Tuberculosis identification 
 
Evidence statement 1: Effectiveness of interventions aiming to improve TB identification 
among migrants  
Pre-migration screening 
1·1 Moderate evidence from four studies reporting on the effectiveness of including sputum culture 
as part of pre-migration screening in migrants to the United States (US) suggested that more active 
tuberculosis (TB) cases are identified during pre-migration screening and less active TB cases are 
diagnosed in the country of destination (Lowenthal et al.,2011 [+]; Assael et al., 2013 [-]; Posey et 
al., 2014 [-] and Lui et al., 2015 [+]).1-4 
Lowenthal et al., 2011 [+] showed a decrease (4·2% to 1·5%) in newly diagnosed TB cases in migrants 
from countries that implemented the new US TB screening strategy.1 Assael et al., 2013 [-] concluded 
that 8 out of 10 culture confirmed TB cases in Mexican migrants to the US, were missed if sputum 
culture was not used for TB screening.2 Posey et al., 2014 [-] concluded that the new screening 
programme improved identification of active TB cases.3 The most recent study by Lui et al., 2015 [+] 
found that more than 50% of the diagnosed TB cases were smear-negative and culture-positive; the 
number of active TB cases among migrants diagnosed within one year of arrival in the US decreased 
from 1,500 per year to 940 per year; and the follow-up in the US improved by 13·7%.4 
 
1·2 Weak evidence from Mor et al., 2012 [+] showed that pre-migration screening by chest X-ray 
(CXR) had a high sensitivity and specificity for identification of TB among migrants from high 
endemic countries.5 
 
1·3 Weak evidence reported by the NICE review6 from one before-and-after study (Mor et al., 2008 
[-]) suggested that pre-migration screening in Ethiopian migrants moving to Israel may reduce the 
risk of developing TB in Israel compared to post-migration screening, with a reduction in time 
between entry into Israel and TB diagnosis (Odds Ratio (OR) = 0·72, 95% Confidence Interval 
(95% CI) 0·59-0·89; p-value (p) = 0·002).7 The study did not adjust for potential differences in TB 
incidence between the cohorts screened over different time periods. 
 
1·4 The NICE review6 reported inconclusive evidence from one retrospective cohort study 
(Sciortino et al., 1999 [+])8 on the effectiveness of pre-migration screening of latent TB infection to 
identify active TB among US migrants within the first year of arrival in the US. 
 
Post-migration screening 
1·5 The NICE review6 reported moderate evidence from three retrospective cohort studies (Verver 
et al., 2001 [+]; Monney and Zellweger, 2005 [+] and Laifer et al., 2007 [+]), suggesting that active 
screening by CXR and/or tuberculin skin test (TST) reduced the number of identified symptomatic 
TB cases and reduced the number of sputum smear or culture positive cases.9-11 However, these 
studies did not adjust for differences in baseline characteristics between the intervention (active 
screening) and control groups (passive presentation).  
 
1·6 Weak evidence from Mor et al. 2015 [+] showed that CXR had a sensitivity of 100% and 
specificity of 96·1% to screen for TB in migrants from high endemic countries.12 
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1·7 Weak evidence from Schneeberger Geisler et al., 2010 [+] suggested that TB screening by 
symptom-based questionnaire had a low sensitivity (55·2%), a high specificity (96·0%) and that the 
time from diagnosis to start of treatment was prolonged (40 days).13  
 
1·8 Weak evidence from two studies on the effectiveness of TB screening by Interferon Gamma 
Release Assay (IGRA) or TST. Painter et al., 2013 [+] showed that TST screening using a 10 mm 
induration as cut off and QuantiFERON-TB Gold Test (QFT-G) had a similar sensitivity (86·4% (95% 
CI: 79·3% - 91·7%) and 81·1% (95% CI: 73·3% - 87·5%), respectively) when screening for culture 
confirmed TB cases in migrants from a high endemic country with a high coverage of BCG 
vaccination.15  
Chuke et al. 2014 [-] showed that QFT-G had a better agreement with CXR than TST but the PPV 
was similar for both tests in migrants from a high endemic country with a high coverage of BCG 
vaccination.16  
 
1·9 Weak evidence from George et al., 2011 [-] suggesting that a TST cut of point of 10 mm would 
be more sensitive and specific for latent TB and active TB in adopted children than a 5 mm TST cut 
of point.17 This study had major limitations, the sample size was too small and only a small number 
of children had a comparative test done (CXR).  
 
Other measurements 
1·10 Moderate evidence from two studies identified by this review (Bell et al., 2013 [+] and Harstad 
et al., 2014 [-]) showed that active referral increased the screening uptake among migrants.18,19   
 
Evidence statement 2: Cost-effectiveness of interventions aiming to improve TB identification 
among migrants 
The NICE review6 found five studies focussing on an economic evaluation of interventions aiming 
to improve identification of active TB among migrants (Dasgupta et al., 2000 [+];Schwartzman and 
Menzies, 2000 [++];Schwartzman et al., 2005 [++]; and Mor et al., 2008 [-])7,20-22 This review found 
two studies that reported on the cost-effectiveness of TB screening interventions (Mor et al., 2012 
[+] and Mor et al., 2015 [+])5,12 
 
2·1 Moderate evidence from five economic studies suggesting that screening by CXR among 
migrants is cost-effective and less costly than screening by TST per case identified5,12,21,22 and cost-
saving when secondary transmission of TB disease is taken into account.21 Adding TST to a 
screening algorithm with a CXR did not result in cost-savings for new entrants.22 Although the 
studies are of varying quality, they all supported the same conclusions. 
 
2·2 Weak evidence from Dasgupta et al., 2000 [+] suggesting that active case finding had an 
incremental cost of $20,328 for treating active TB compared with passive case detection and would 
have only been cost-saving if the future risk of TB was higher than the baseline estimate of 0·05%.20  
 
2·3 Weak evidence from Mor et al., 2008 [-] suggesting that pre-migration screening has a direct 
net saving of $449,817 over five years compared to post-migration screening.7  
 
Evidence statement 3: Effectiveness of interventions aiming to improve TB identification among 
homeless people  
3·1 Weak evidence from Bernard et al., 2012 [+] showed that screening homeless people by Mobile 
X-ray Unit (MXU) improved screening coverage and reduced TB transmission among homeless 
people using shelters but also among non-shelter users.23 
 
Seven studies identified by the NICE review6 reported on the use of incentives, two studies focussed 
on homeless people (Citron et al., 1995 [+] and Pilote et al., 1996 [++]).24,25 
 
3·2 Moderate evidence from two studies (Citron et al., 1995 [+] and Pilote et al., 1996 [++]) showed 
that the screening uptake improved among homeless people when a monetary incentive was given.24,25   
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Evidence statement 4: Effectiveness of interventions aiming to improve TB identification 
among drug users 
4·1 Weak evidence from two studies (Ruutel et al., 2011 [+], Duarte et al., 2011 [-]) showed that 
active referral of intravenous drug users to a TB clinic increased TB screening among drug users for 
minimal extra costs.26,27 
 
Monetary incentives 
Two studies identified by the NICE review6 reported on the use of incentives, one study reported on 
the effectiveness of the use of incentives among drug users (Perlman et al., 2003 [++])28 and one study 
reported on the cost-effectiveness (Perlman et al., 2001 [++])31. 
 
4·2 Moderate evidence from one study showing that the use of small monetary incentives improved 
the attendance for TB screening by CXR among drug users with a positive TST.28 
 
4·3 Weak evidence from one study showed that the provision of monetary incentives to drug users 
improved TB screening and was cost-effective.29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evidence statement 6: Cost-effectiveness of interventions aiming to improve TB identification 
among prisoners 
Weak evidence from one cost-comparison study identified by the NICE review6 (Jones and 
Schaffner, 2001 [+])32 suggesting that screening for active TB among prisoners was most cost-
effective if it was done by CXR ($9,600 per positive case) compared to TST ($32,100) or symptom-
based questionnaire ($54,100). The findings of this study are of limited quality as the incremental 
Evidence statement 5: Effectiveness of interventions aiming to improve TB identification 
among prisoners 
Two studies identified by the NICE review6 (Puisis et al., 1996 [-] and Yates et al., 2009 [-])30,31 
reported on the effectiveness of interventions aiming to improve TB identification among prisoners.  
 
5·1 Weak evidence from one before-and-after study identified by the NICE review6 (Puisis et al., 
1996 [-]), suggesting that the yield of identifying active TB among prisoners was comparable when 
screening was done by TST (0·069%) or by CXR (0·056%).30 The findings are of limited quality as 
there was no statistical analysis done and no adjustment for baseline differences between the two 
groups was done.  
 
5·2 Weak evidence from one retrospective cohort study identified by the NICE review6 suggesting 
that all prisoners should be offered TB screening by MXU regardless if the prisoners present with 
TB symptoms, as a substantial number of TB cases will be missed if only symptomatic prisoners 
will be screened.31 Due to the retrospective character of this study the conclusions that could be 
drawn from this study were limited.  
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cost-effectiveness ratio was not calculated and the start-up costs for CXR were not included in the 
cost calculation.  
 
Evidence statement 7: Effectiveness of interventions aiming to improve TB identification among 
mixed hard-to-reach groups  
Moderate evidence from three studies, one study identified by the NICE review6 (Watson et al., 2007 
[++])33 and two studies identified by this review (Story et al., 2012 [+] and Jit et al., 2011 [+])34,35 
about the effectiveness of TB screening by MXU.  
Watson et al., 2007 [++] showed that TB screening by MXU reduced diagnostic delay (adjusted 
hazard ratio = 0·35, 95%CI 0·21 - 0·59, p < 0·0001) and cases identified by MXU were less likely to 
be symptomatic than passively presented cases (adjusted OR 0·35, 95%CI 0·15 to 0·81, p < 0·001).33 
Jit et al., 2001 [+] showed that MXU screening is effective, as 35% of the TB cases identified by 
MXU screening were asymptomatic and would not have presented for TB diagnostics.34 
Story et al., 2012 [+] showed that MXU screening had a high sensitivity (81·8%) and specificity 
(99·2%), and people detected by MXU screening were less infective and therefore TB transmission 
could be reduced.35  
 
Evidence statement 8: Cost-effectiveness of interventions aiming to improve TB identification 
among mixed hard-to-reach groups 
Moderate evidence from two studies, one study identified by the NICE review6 (Watson et al., 2007 
[++])33 and one study identified in this update of the review (Jit et al., 2011 [+]).34   
Watson et al., 2007 [++] showed that screening by MXU was cost-effective compared to passive case 
detection if the costs of TB treatment was assumed to be £10,000, incremental cost-effectiveness ratio 
£1,912·33.33  
Jit et al., 2011 [+] suggested that MXU screening is cost-effective, the incremental cost was £18,000 
per Quality of Life Year (QALY) gained.34  
 
Evidence statement 9: Effectiveness and cost-effectiveness of interventions aiming to improve 
TB identification among sex workers 
No studies were identified that focussed on the effectiveness and/or cost-effectiveness of interventions 
aiming to improve TB identification among sex workers.  
 
Evidence statement 10: Effectiveness of interventions aiming to improve TB identification 
among children within vulnerable and hard-to-reach populations 
Weak evidence from George et al., 2011 [-] suggesting that a TST cut of point of 10 mm would be 
more sensitive and specific for latent TB and active TB in adopted children than a 5 mm TST cut of 
point.17 This study had major limitations, the sample size was too small and only a small number of 
children had a comparative test done (CXR).  
 
Tuberculosis management 
 
Evidence statement 11: Effectiveness of directly observed therapy (DOT) to manage active TB 
in migrants 
Inconsistent evidence from two studies identified by the NICE review36 about the effectiveness of 
DOT in migrants: one study37 (MacIntyre et al. 2003 [+]) found no significant difference in treatment 
completion rates between DOT administered by a family member (96·5% ) and receiving regular 
treatment consisting of monthly check-ups (90·6%; RR for non-completion 2·7, 85% CI 0·66-14·2; 
p=0·11), although this study was underpowered. The second study38 (Chemtob et al., 2003 [-]) 
reported an increase in successful treatment outcome for those who received DOT (78·5% in 1999 
and 76·9% in 2000) vs. standard treatment (26·7%). However, no statistical comparison between these 
differences was made and potential sources of bias remained.  
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Evidence statement 12: Effectiveness of enhanced case management for management of active 
TB in homeless people 
Weak evidence from one study (Goetsch et al. 2012 [-]) that enhanced case management leads to 
high treatment success rates in homeless people.39 The authors found that the involvement of an 
experienced community worker providing education, communication management (between patient 
and health care (HC) professionals) and treatment monitoring, combined with a streamlined screening 
service, led to 76% treatment completion. A limitation is that they compared their post-intervention 
results retrospectively without correction for possible confounders. 
 
Evidence statement 13: Effectiveness of a service model approach/social support to manage 
active TB in homeless people 
The NICE review36 reported weak evidence from one Spanish study (Diez et al. 1996 [-]) that a social 
care programme increased treatment completion.40 They found that their intervention decreased 
annual TB incidence in the homeless population in the district (p=0·03), while it did not in other 
districts (p=0·34). It was not clear whether this change was caused by the intervention. 
 
Evidence statement 14: Effective management of drug users with active TB 
14·1 Moderate evidence from two studies, one identified in this update39 and one41 from the NICE 
review36 showing that enhanced case management leads to improved treatment outcome in drug users. 
The results presented by Goetsch et al. show that community workers providing education and 
facilitating communication with health care professionals combined with streamlined screening 
procedures leads to 72% treatment completion.39 However, a possible source of confounding 
remained by not correcting for time differences in this retrospective effectiveness study. Ricks 2008 
[++] reports moderate evidence that enhanced case management by a former drug user peer led to 
higher treatment completion rates than limited case management by a health worker (Relative Risk 
(RR) =2·68, 95% CI 1·24 to 5·82; p=0·01), although this was a small study with high dropout rates.41 
 
14·2·1 Weak evidence from one study identified in this update that a combination of enhanced case 
management in combination with improved service models could improve treatment outcome of drug 
users.27 Duarte et al. 2011 [-] reported that treatment compliance increased, defaulting rates decreased 
and the mortality rate decreased (OR 0·7, 95% CI 0·28-1·78). Because the results were obtained in 
two different time periods and the authors did not correct for this, the evidence is of limited quality. 
 
14·2·2 One study42 identified by the NICE review36 (Bock et al., 2001 [+]) provided weak evidence 
that in a population in which more than 50% were drug users, adding incentives to Direct Observed 
Treatment (DOT) improved treatment completion rates compared to DOT alone (OR = 5·73, 95% CI 
2·25-14·84).42 
 
14·3 One study from the NICE review36 (Alwood, 1994 [-]) provided weak evidence that DOT led to 
a significantly higher treatment adherence when people living with HIV (64% being intravenous drug 
users) received DOT (96%, 44/48) compared with standard treatment (76%, 22/30, p=0·02).43 
However, only data for patients who adhered to treatment for more than eight weeks was reported. 
 
14·4 One study from the NICE review36 (Oscherwitz et al. 1997 [-]) provided weak evidence that in 
a population mainly consisting of drug or alcohol users (81%), treatment completion increased when 
patients were not detained: 82% of participants who were not detained completed treatment versus 
20% who were (p<0·001).44 However, significant differences were found between the two groups that 
may have confounded the results. 
 
Evidence statement 15: Effective management of prisoners with active TB 
One study from the NICE review36 (Rodrigo et al., 2002 [-]) provided weak evidence that prisoners 
with active TB showed improved treatment adherence with DOT (from 95 per 100 in 1993 to 100 per 
100 in 2000; controls 60 per 100 in 1987 to 76 per 100 in 1992).45 No details were given about the 
sample characteristics. 
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Evidence statement 16: Effectiveness of concurrent antiretroviral therapy (ART) and TB 
therapy in people living with HIV (Human Immunodeficiency Virus) co-infected with active TB  
Weak evidence from one study identified in this update that concurrent ART and TB therapy in 
people living with HIV co-infected with active TB leads to decreased mortality. Girardi et al. [+] 
report a successful TB outcome in 52·8% of the included patients co-infected with TB and HIV, 
32·5% had an unsuccessful outcome and 14·6% died.46 Concurrent ART and TB treatment reduces 
the mortality rate by six fold. Those who were not ART-naïve and not receiving ART during TB 
treatment had a fourfold higher chance of dying.  
 
Evidence statement 17: Effectiveness of early initiation of ART in people living with HIV co-
infected with active TB 
Conflicting evidence from one study that early initiation of ART in people living with HIV co-
infected with active TB is effective. Girardi et al. [+] conclude that with a six fold reduction in 
mortality, ART should be started as early as possible.46  
 
Evidence statement 18: Effectiveness of DOT in the management of people living with HIV co-
infected with active TB 
One study identified by the NICE review36 (Alwood, 1994) provided weak evidence that DOT can 
improve treatment adherence.43 In the DOT group, 96% (44/48) completed six months of therapy 
versus 76% (22/30) in the standard treatment group. However, since patients who failed to adhere to 
more than eight weeks of treatment were excluded from the analysis these results are of limited 
quality. 
 
Evidence statement 19: Effectiveness of combined interventions in the management of mixed 
hard-to-reach populations with active TB 
19·1 Weak evidence from Goetsch et al. 2012 [-] that enhanced case management combined with 
improved service models leads to improved TB treatment outcome.39 With an experienced community 
worker involved in and responsible for caring for these patients, as well as a streamlined low-threshold 
screening process, several active TB cases could be identified and treated, with a treatment completion 
rate of 76·3%. 
 
19·2 One study identified by the NICE review36 (Déruaz & Zellweger, 2004 [-]) provided weak 
evidence that the treatment outcome of patients undergoing full DOT (89·5%) does not significantly 
differ from that of patients undergoing partial DOT (89·5%), where only the first two months of 
treatment were observed (p=1·0).47 Treatment outcome did not differ significantly between providing 
DOT on site (92·6%) or via social outreach (85·2%; p=0·67). Evidence is of limited quality because 
of differences and biases in data collection, and patients at risk for non-adherence were assigned to 
full DOT. 
 
19·3 One study identified by the NICE review36 (Juan et al., 2006 [+]) provided weak evidence that 
DOT combined with incentives improved treatment completion rates among mixed hard-to-reach 
populations compared to self-administration (RR = 3·07, 95% CI 2·13-4·41).48 However, evidence is 
of limited quality because the intervention group was compared with a retrospective cohort without 
being corrected for differences. 
 
Evidence statement 20: Cost-effectiveness of enhanced case finding and improved service 
models for mixed hard-to-reach populations with active TB 
Weak evidence from Jit et al. 2011 [+] that a mobile “Find and Treat” service that predominantly 
screens homeless individuals and drug users is cost-effective.34 It is estimated that the service would 
cost £6,400 per QALY gained with an incremental cost ratio of the mobile screening unit of 
£18,000/QALY gained. 
 
Evidence statement 21: Effectiveness and cost-effectiveness of interventions for sex-
workers with active TB 
No evidence for effective or cost-effective TB interventions for sex-workers with active TB was 
identified in the NICE review36 or this review. 
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Evidence statement 22: Effectiveness and cost-effectiveness of interventions on children within 
vulnerable and hard-to-reach populations 
No evidence for effective or cost-effective interventions on children within vulnerable and hard-to-
reach populations with active TB was identified in the NICE review36 or this review. 
 
List of Abbreviations 
ART = Antiretroviral Therapy; CXR = Chest X-ray; DOT = Direct Observed Treatment; HC = Health Care; 
HIV = Human Immunodeficiency Virus; IGRA = Interferon Gamma Release Assay; IRIS = Immune 
Reconstitution Inflammatory Syndrome; LTBI = Latent TB Infection; MXU = Mobile X-ray Unit; OR = Odds 
Ratio; p = p-value; QALY = Quality Adjusted Life Year; QFT-G = QuantiFERON-TB Gold Test; RR = 
Relative Risk; TB = Tuberculosis; TST = Tuberculin Skin Test; US = United States; 95% CI = 95% Confidence 
Interval 
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Supplementary Material V - Quality Assessment 
 
Table S1. Quality assessment of included effectiveness studies 
 Questions about:               Population                 Method of selection                            Outcomes                                 Analysis               Summary 
Year First author (year) 1·1 1·2 1·3 2·1 2·2 2·3 2·4 2·5 3·1 3·2 3·3 3·4 3·5 4·1 4·2 4·3 4·4 5·1 5·2 Score 
 Studies identified for this review 
2010 Schneeberger et al.45  ++ ++ ++ + ++ ++ - ++ ++ + - ++ ++ + ++ - ++ + + + 
2011 Duarte et al.40  ++ + - NA + ++ - ++ + + - + ++ NA + - + - - - 
2011 George et al.41  ++ + + ++ ++ + - ++ - - - NA - - - + + - - - 
2011 Lowenthal et al.43  ++ + ++ + ++ ++ - + ++ ++ - + + + ++ - + + + + 
2011 Ruutel et al.44  ++ - + + ++ ++ + ++ ++ - - ++ NR - ++ ++ + + + + 
2012 Bernard et al.37  ++ ++ + - ++ NA NA ++ ++ + + NA NA + + - ++ - + + 
2012 Chuke et al.31  ++ + + - - NA - + - - - NR NA - - - - - - - 
2012 Girardi et al.47  ++ ++ + NA ++ NA ++ ++ + + - NA ++ NR ++ ++ ++ + + + 
2012 Goetsch et al.46  ++ + - NA + ++ - ++ ++ - - NA NA NR ++ - - - - - 
2012 Mor et al.38  + ++ ++ NA + NA NR + + ++ + NA ++ ++ + - + + ++ + 
2012 Story et al.39  ++ + + - - NA + ++ + - - NA ++ - + + + + + + 
2013 Assael et al.34  + ++ + NR + NA - + ++ - - NA NA NR - - - - - - 
2013 Bell et al.35  ++ + ++ - ++ ++ + ++ ++ + - + + + + + ++ + + + 
2013 Painter et al.36  ++ ++ ++ ++ ++ NA NA + ++ ++ - ++ ++ - ++ - + + + + 
2014 Posey et al.33  + - - ++ - + - ++ - + - NR NR - - - - - - - 
2015 Liu et al.29  ++ ++ ++ ++ ++ + - + ++ ++ - ++ ++ ++ ++ + - - ++ + 
2015 Mor et al.30  + - - - + NA - + + - - NA - - - - - - - - 
 Studies identified for the NICE reviews24,25 
1994  Alwood et al.67 + + ++ - + ++ - + + ++ + ++ ++ NR - + + - - - 
1995 Citron et al.50 ++ ++ + + ++ + + ++ ++ ++ ++ + ++ NR + - + + + + 
1996 Diez et al.71 + + - - - NR NA + - NA - ++ ++ NR NR + ++ - - - 
1996 Pilote et al.56 + ++ + ++ ++ NR ++ ++ + ++ ++ ++ NR NA NA ++ ++ ++ + ++ 
1996 Puisis et al.59 ++ + ++ - + ++ - + + + + NR NR NR - - - - - - 
1997 Oscherwitz et al.74 + + + NA + ++ ++ + + ++ ++ NR NR NR - ++ + - + - 
1999 Sciortino et al.63 + + ++ + - NR + + ++ ++ ++ ++ ++ NR ++ ++ ++ ++ + + 
2001 Bock et al.68 + + ++ ++ + ++ ++ + ++ ++ + ++ ++ NR + ++ ++ ++ + + 
2001 Verver et al.64 ++ ++ + - + NR - + ++ + ++ ++ ++ NR - + ++ + + + 
2002 Rodrigo et al.75 + ++ NR NA + ++ ++ + + ++ ++ NR NR NR NR ++ + - + - 
2003 Chemtob et al.69 ++ + - NA + ++ ++ + + ++ + NR NR NR NR - - - + - 
2003 MacIntyre et al.73 + + + ++ ++ ++ + + + ++ + ++ ++ - NR + + + + + 
2003 Perlman et al.57 ++ + ++ + ++ + + + ++ ++ ++ ++ ++ NR ++ ++ ++ ++ + ++ 
2004 Deruaz & Zellweger70 ++ + + - + - - + - ++ ++ ++ ++ NR - ++ + - + - 
2005 Monney and Zellweger54 ++ + NR - ++ ++ - + + + + ++ ++ NR - - + - + + 
2006 Juan et al.72 ++ + + - ++ ++ ++ + ++ ++ + ++ ++ NR + ++ ++ + + + 
2007 Laifer et al.53 ++ ++ ++ - ++ ++ - + ++ ++ + NR NR NR - ++ + - + + 
2008 Ricks60 ++ + ++ ++ ++ ++ ++ + + ++ ++ ++ + NR ++ ++ ++ ++ + ++ 
2009 Yates et al.66 ++ + + + + ++ + ++ - + ++ NA + NR - + - + - - 
NICE  National Institute for Health and Clinical Excellence 
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++ well designed study, minimal risk of bias 
+ study may not have addressed all potential sources of bias 
-  significant risk of bias 
NA Not Applicable 
NR Not Reported 
 
 
Quality assessment questions for effectiveness studies: 
1·1  Is the source population or source area well described?  
1·2  Is the eligible population or area representative of the source population or area?  
1·3  Do the selected participants or areas represent the eligible population or area?  
2·1  Selection of exposure (and comparison) group. How was selection bias minimised?  
2·2  Was the selection of explanatory variables based on a sound theoretical basis?  
2·3  Was the contamination acceptably low?  
2·4  How well were likely confounding factors identified and controlled?  
2·5  Is the setting applicable to Europe?  
3·1  Were the outcome measures and procedures reliable?  
3·2  Were the outcome measurements complete?  
3·3  Were all the important outcomes assessed?  
3·4  Was there a similar follow-up time in exposure and comparison groups?  
3·5  Was follow-up time meaningful?  
4·1  Was the study sufficiently powered to detect an intervention effect (if one exists)?  
4·2  Were multiple explanatory variables considered in the analyses? 
4·3  Were the analytical methods appropriate?  
4·4  Was the precision of association given or calculable? Is association meaningful?  
5·1  Are the study results internally valid (i.e. unbiased)?  
5·2  Are the findings generalisable to the source population (i.e. externally valid)?  
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Table S2. Quality assessment of included cost-effectiveness studies 
 
 Questions about:                                    Applicability                                                                                Study limitations 
Year First author  1·1 1·2 1·3 1·4 1·5 1·6 1·7 1·8 2·1 2·2 2·3 2·4 2·5 2·6 2·7 2·8 2·9 2·10 2·11 Overall 
 Studies identified for this review 
2011 Jit et al.42 Y Y Y Y NA Y Y Y Y Y Y Y Y Y Y Y Y Y N Minor 
limitations 
 Studies identified for the NICE reviews24,25 
2000 Dasgupta et al.51  Y Y PA N PA PA N PA Y Y Y PA N PA PA PA Y Y U/C Potential 
serious 
limitations  
2000 Schwartzman and 
Menzies62 
Y Y PA Y PA Y N PA Y Y Y PA PA Y PA PA Y Y N Minor 
limitations 
2001 Jones and 
Schaffner52 
PA Y PA Y A Y N PA Y Y Y PA Y Y PA PA Y Y U/C Potential 
serious 
limitations 
2001 Perlman et al.58 Y Y PA Y Y Y N PA Y Y Y Y Y Y PA PA Y Y U/C Minor 
limitations 
2005 Schwartzman et 
al.61 
Y Y PA Y Y PA N Y PA Y Y PA PA Y PA PA N Y N Minor 
limitations 
2007 Watson et al.65 Y Y Y Y PA Y Y PA PA PA PA PA PA Y PA PA Y Y N Minor 
limitations 
2008 Mor et al.55 PA Y PA N PA N N PA PA PA PA N PA PA U/C U/C Y N N Very serious 
limitations 
 
 
NICE  National Institute for Health and Clinical Excellence 
Y Yes to question 
N No to question 
PA Partially applicable 
NA Not Applicable 
U/C  Unclear 
 
 
Quality assessment questions for cost-effectiveness studies:  
1·1 Is the study population appropriate for the topic being evaluated? 
1·2 Are the interventions appropriate for the topic being evaluated? 
1·3 Is the system in which the study was conducted sufficiently similar to the current European context? 
1·4 Was/were the perspective(s) clearly stated and what were they? 
1·5 Are all direct health effects on individuals included, and are all other effects included where they are material? 
1·6 Are all future costs and outcomes discounted appropriately? 
 61 
1·7 Is the value of health effects expressed in terms of quality-adjusted life years (QALYs)? 
1·8 Are costs and outcomes from other sectors fully and appropriately measured and valued? 
2·1 Does the model structure adequately reflect the nature of the topic under evaluation? 
2·2 Is the time horizon sufficiently long to reflect all important differences in costs and outcomes? 
2·3 Are all important and relevant outcomes included? 
2·4 Are the estimates of baseline outcomes from the best available source? 
2·5 Are the estimates of relative 'treatment' effects from the best available source? 
2·6 Are all important and relevant costs included? 
2·7 Are the estimates of resource use from the best available source? 
2·8 Are the unit costs of resources from the best available source? 
2·9 Is an appropriate incremental analysis presented or can it be calculated from the data? 
2·10 Are all important parameters whose values are uncertain subjected to appropriate sensitivity analysis? 
2·11 Is there any potential conflict of interest? 
  
 62 
Table S3. Quantitative Intervention Studies 
 Questions 
about:                                                           
Population Method of selection Outcomes Analysis Summary  
Year First Author  1·1 1·2 1·3 2·1 2·2 2·3 2·4 2·5 2·6 2·7 2·8 2·9 2·10 3·1 3·2 3·3 3·4 3·5 3·6 4·1 4·2 4·3 4·4 4·5 4·6 5·1 5·2 Over-all 
 Study identified for this review 
2014 Harstad et al.32  + ++ ++ + - NA NA ++ ++ - + ++ ++ ++ ++ + + NA NA ++ NR NR NR + ++ + ++ - 
 
++ Well designed study, minimal risk of bias 
+ Study may not have addressed all potential sources of bias 
-  Significant risk of bias 
NA Not Applicable 
NR Not Reported 
 
Quality Assessment Questions: 
1·1 Is the source population or source area well described? 
1·2 Is the eligible population or area representative of the source population or area? 
1·3 Do the selected participants or areas represent the eligible population or area? 
2·1 Allocation to intervention (or comparison). How was selection bias minimised? 
2·2 Were interventions (and comparisons) well described and appropriate? 
2·3 Was the allocation concealed? 
2·4 Were participants or investigators blind to exposure and comparison? 
2·5 Was the exposure to the intervention and comparison adequate? 
2·6 Was contamination acceptably low? 
2·7 Were other interventions similar in both groups? 
2·8 Were all participants accounted for at study conclusion? 
2·9 Did the setting reflect European practice? 
2·10 Did the intervention or control comparison reflect European practice? 
3·1 Were outcome measures reliable? 
3·2 Were the outcome measurements complete? 
3·3 Were all the important outcomes assessed? 
3·4 Were outcomes relevant? 
3·5 Were there similar follow-up times in exposure and comparison groups? 
3·6 Was follow-up time meaningful? 
4·1 Were exposure and comparison groups similar at baseline? If not, were these adjusted? 
4·2 Was intention to treat (ITT) analysis conducted? 
4·3 Was the study sufficiently powered to detect an intervention effect (if one exists)? 
4·4 Were the estimates of effect size given or calculable? 
4·5 Were the analytical methods appropriate? 
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4·6 Was the precision of intervention effects given or calculable? Were they meaningful? 
5·1 Are the study results internally valid (i.e. unbiased)? 
5·2 Are the findings generalisable to the source population (i.e. externally valid) 
 
 
 
 
 
